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CEREBRAL SMALL VESSEL DISEASE
Cerebral small vessel disease (cSVD) encompasses a spectrum of pathologies with different 
aetiologies that affect small arteries, arterioles, venules and capillaries of the brain. Arteriolo-
sclerosis and cerebral amyloid angiopathy are the most common forms of cSVD.1 In this thesis, 
we refer to arteriolosclerosis when addressing cSVD.
Arteriolosclerosis is also known as age- and vascular risk factor-related cSVD as it is strongly 
associated with ageing, diabetes and hypertension. Pathological findings in the small vessels 
of post-mortem patients include loss of smooth muscle cells, lipohyalinosis, thickening of the 
vessel wall and narrowing of the lumen.1, 2 Recent developments in high field MR imaging make 
it possible to visualize some of these small vessels in vivo. However, 7T or 9.4T MRIs are not yet 
widely available and not used in routine clinical practice. Moreover, they are accompanied with 
an increase of imaging artefacts. The manner in which normal anatomy and disease appear with 
changes in contrast and resolution at high field is also still unclear.3 As such, most research in 
cSVD in vivo is based on visible structural brain changes on conventional brain MRI, which are 
considered as surrogate markers for cSVD. These abnormalities include white matter hyperin-
tensities (WMH), lacunes, cerebral microbleeds and perivascular spaces.4-6
These MRI markers can be clinically silent and have been described in the healthy elderly pop-
ulation. However, cSVD also plays a crucial role in several clinically overt disorders, of which 
lacunar stroke and vascular cognitive impairment (VCI) are the most common ones.7-11
Lacunar stroke accounts for about 25% of all ischemic strokes and can be identified by rather 
specific lacunar stroke syndromes. It is caused by a lacunar infarct deep in the brain. Some 
lacunar stroke patients also show additional ‘silent’ asymptomatic lacunes, white matter hyper-
intensities, perivascular spaces or cerebral microbleeds on brain imaging. 
VCI refers to cognitive impairment linked to cerebrovascular disease ranging from mild VCI 
to vascular dementia.12 Mild VCI is a condition between normal cognition and dementia.13 
This condition includes objective deficits relative to normative values as well as objective and 
subjective impairments in any of several cognitive domains such as executive function, infor-
mation processing speed and memory.14 Patients who have mild VCI are considered to be at 
risk for developing dementia.13 cSVD is regarded the most common cause for mild VCI. A high 
prevalence of cognitive decline has been documented during follow-up in subjects with mul-
tiple lacunes.1 Similarly, WMH have been repeatedly associated with cognitive problems, and 
progression of WMH load is associated with further cognitive decline.13 Cerebral microbleeds 
and perivascular spaces have also been related to lower cognitive function.15, 16
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PATHOPHYSIOLOGY OF CSVD
Although common risk factors such as hypertension and diabetes need to be treated, 
specific therapies for prevention and treatment of cSVD are lacking, largely because the 
pathophysiological mechanisms of cSVD remain elusive. Multiple processes have been 
considered to be involved in cSVD, including blood-brain barrier dysfunction, loss of 
microstructural integrity, changes in cerebral flow and perfusion, inflammatory and immu-
nological processes, capillary dysfunction and glycocalyx disruption.1, 17, 18 Yet, the exact 
pathways in this multifactorial disorder remain unclear. New imaging techniques can bring 
more insight in the pathophysiological processes and their interaction. In this thesis we will 
use dynamic contrast-enhanced MRI (DCE-MRI), IVIM MRI and sublingual microvascular 
imaging to study cSVD. 
Although multiple processes are thought to be involved in the pathophysiology of cSVD, we 
focus on four main processes in this thesis: blood-brain barrier leakage, reduced microstruc-
tural integrity, microvascular blood flow changes and capillary dysfunction. We will elaborate 
on these four processes, followed by the novel imaging techniques that can be applied to gain 
further insight in these processes.
Permeability of the blood-brain barrier
The blood-brain barrier (BBB) is a highly specialized brain structure that is part of the neu-
rovascular unit (NVU) which regulate the close relationship between metabolic demand and 
neuronal activity in the brain. The NVU is composed of the vascular endothelium, astrocytes, 
pericytes, neurons and extracellular matrix around the vessels. The BBB, which is formed by the 
endothelial lining of the vascular walls together with the tight junctions, protects the neuronal 
microenvironment and secures proper functioning of the brain by separating harmful compo-
nents of the blood circulation from neurons, and by maintaining the chemical composition of 
the neuronal environment.19, 20 
Disruption of the BBB may lead to an increase in permeability and therefore in altered transport 
of molecules between blood and brain and vice versa. Furthermore, it can result in dysfunction 
of the NVU, aberrant angiogenesis, brain hypoperfusion and inflammatory responses, eventu-
ally leading to progressive synaptic and neuronal dysfunction.19, 21 
It has been proposed that BBB dysfunction may play a pivotal role in the pathophysiology 
in cSVD.22 The hypothesis states that cardiovascular risk factors and genetic factors contrib-
ute to the initial endothelial damage of cerebral blood vessels leading to BBB dysfunction. 
Increased permeability of the BBB leads to leakage of blood components in and through 
the vessel wall, inducing an inflammatory process in the vessel wall. This will result in 
GENERAL INTRODUCTION
 11
1
anatomical and functional changes of the vessel wall. Eventually, this leads to enlarged 
perivascular spaces, small vessel occlusion and lacunes, cerebral microbleeds and white 
matter parenchymal damage. Although it is a plausible hypothesis, the exact role of BBB 
dysfunction in cSVD, and the difference with normal ageing, is still unclear.1 Pathological 
studies have shown an increase of interstitial fluid and perivascular oedema-related lesions 
in the WMH, suggestive for BBB involvement in cSVD.23-25 Moreover, biochemical studies 
using CSF-serum albumin ratios showed that BBB permeability increases with age and that 
increased BBB permeability is associated with vascular dementia.26 While post-mortem 
material is scarce and may be confounded by post-mortem tissue changes, and CSF studies 
are invasive and patient unfriendly, a recently explored MRI technique enables in vivo and 
non-invasive studies of BBB permeability in patients with cSVD. This technique is named 
dynamic contrast-enhanced (DCE) MRI. 
Dynamic contrast-enhanced MRI
DCE-MRI enables serial acquisition of images before and after injection of gadolinium-based 
contrast agent. Signal enhancement in brain tissue is considered to be an indication of contrast 
agent leaking across the BBB. By analysing the slope of the tissue signal enhancement curve 
over time, a semi-quantitative (i.e. relative) measure of BBB permeability can be obtained. Using 
this semi-quantitative method, patients with lacunar stroke with extensive WMH were shown 
to have increased permeability in the normal-appearing white matter (NAWM) compared with 
healthy controls.27 Furthermore, patients with lacunar stroke showed higher permeability in 
the white matter compared with patients with cortical stroke, the latter being regarded as large 
vessel disease.28 
While semi-quantitative studies are limited, quantitative data on BBB permeability in cSVD 
are even scarcer. Up until now, only one quantitative study was performed, which showed an 
increase of BBB leakage in patients with VCI compared with controls.29 Quantitative studies are 
essential to interpret results of longitudinal studies and to compare results from different stud-
ies. In this thesis, the combination of DCE-MRI, pharmacokinetic modelling using the Patlak 
model, and histogram analysis, enabled us to provide two quantitative physiological parameters 
for BBB permeability: 1) leakage rate which represents the magnitude of leakage, and 2) leakage 
volume which represents the spatial extent of brain tissue that shows leakage. 
To acquire a better understanding of the role of BBB dysfunction in cSVD, it is essential to 
study the quantitative differences in BBB permeability between patients with cSVD and normal 
ageing. Additionally, associations with the extent of radiological and clinical changes associated 
with cSVD, such as WMH volume and cognitive function require further study. Findings on 
these associations are rare and conflicting. One semi-quantitative study found an association 
between higher BBB leakage rate and higher WMH load.30 However, in another study, such an 
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association was not found.31 Further, one single semi-quantitative study that examined the rela-
tionship between BBB permeability and cognition, found no cross-sectional but a longitudinal 
relationship between BBB leakage rate and cognitive decline.32 
Microstructural integrity 
It has been postulated that besides macrostructural changes seen on MRI, decrease of micro-
structural integrity of the brain parenchyma is an important nonvisible marker of cSVD.33 It has 
also been shown that microstructural integrity plays an important role in cognitive dysfunction 
associated with cSVD.18 
Microstructural integrity has mainly been studied in the white matter, using diffusion tensor 
imaging (DTI) in which increased mean diffusivity and decreased fractional anisotropy often 
serve as surrogate markers for loss of tissue integrity (or tissue changes). These studies demon-
strated a decrease of microstructural integrity in the NAWM and WMH in patients with cSVD 
compared with controls.34, 35 Moreover, WMH showed lower structural integrity compared with 
NAWM, and NAWM directly surrounding WMH showed lower structural integrity compared 
with NAWM further off, suggesting onset of white matter damage prior to visual white matter 
changes on MRI (i.e. WMH).36 Other DTI studies showed associations between lower micro-
structural integrity in the white matter and lower cognitive function in cSVD patients.37, 38 
Although DTI is sensitive in detecting structural damage beyond the conventional visible paren-
chymal damage, it does not provide information of the underlying cause. Several mechanisms, 
including BBB dysfunction, cerebral blood flow changes, and reduced vasoreactivity have been 
proposed to cause these white matter damages.33 Moreover, the diffusivity measure acquired by 
DTI is contaminated by a contribution of diffusion in the blood space. Intravoxel incoherent 
motion is an MRI technique that separates tissue diffusivity and blood space diffusivity and 
provides information on microstructure and microvascular flow concurrently (see below).
Microvascular blood flow
Many studies have examined cerebral blood flow (CBF) in cSVD and found that cSVD is related 
to lower CBF compared with controls, but conflicting results exist.33, 39 Studies measuring flow 
velocity in the middle cerebral artery using Trans-Doppler showed that CBF decrease relates 
to ageing, hypertension and WMH. 40, 41 CT, positron emission tomography (PET), and single 
photon emission CT (SPECT) require ionizing radiation and injection of exogenous contrast 
agent measures, and studies using these techniques showed correlation between CBF and 
cSVD.42-44 Moreover, some CT studies found a lower CBF in patients with cognitive impair-
ment compared with controls, but results are conflicting.43, 45 Arterial spin labelling (ASL) is an 
fMRI technique and quantifies cerebral blood flow, using intravascular water as endogenous 
tracer. In subjects with cSVD, lower CBF was found in the WMH than in the NAWM or in the 
GENERAL INTRODUCTION
 13
1
grey matter.46 One ASL study proposed that steal phenomenon is a factor in producing WMH: 
areas in the white matter where there is a reduced cerebrovascular reserve are more susceptible 
in producing WMH.47 A recent review proposed that CBF first increases in response to mild 
capillary dysfunction, but when the dysfunction becomes more severe, CBF attenuates to pre-
vent functional shunting.17
It can be concluded that although many studies on CBF in cSVD exist, the exact role of blood 
flow changes in the pathophysiology of cSVD remains unclear. Some postulated that reduced 
cerebral flow is one of the early changes seen in cSVD. This reduction would cause hypoxia and 
consequently leads to neuronal damage and reduction of microstructural integrity.17 Others 
favoured the hypothesis that microstructural degeneration results in a reduced (local) metabolic 
and thus vascular demand, which in turn leads to a reduction of CBF.33 More studies with con-
joined examination of microstructure and cerebral blood flow are needed to gain more insight 
in these mechanisms. 
Intravoxel incoherent motion MR
Intravoxel incoherent motion (IVIM) is an MR sequence that is designed to separate the micro-
structural and the vascular component.48 It is a non-invasive diffusion weighted MRI technique. 
As opposed to conventional diffusion weighted techniques where the parenchymal signal is 
contaminated by microvascular signal, IVIM quantitatively assesses all motions that contribute 
to the signal acquired with diffusion MRI. These motions include molecular diffusion of water 
in the brain tissue (a surrogate marker for microstructural integrity) and the capillary circula-
tion (microvascular blood flow).49 IVIM has been applied in gliomas and stroke but not yet in 
cSVD.50 As cSVD has been suggested to relate to changes in parenchymal microstructure and 
microvascular blood flow, IVIM can be of particular interest in studying the role of microstruc-
ture and blood flow concomitantly.
Moreover, studies on the direct relationship between cerebral microvascular blood flow and 
cognitive function in cSVD are lacking, and no data is available on whether there is an inter-
action between microstructure and microvascular blood flow in cognitive function in cSVD. 
IVIM combined with cognitive tests may be useful to provide insights in these relationships.
Neurovascular coupling and capillary function 
Neurovascular coupling is the dynamic changing capacity of local vascular perfusion matching 
changes of local neuronal metabolism. When neuronal activity increases, more oxygen and 
nutrients need to be delivered to the location of activity increase to secure adequate tissue 
perfusion and function.51 As the exchange of oxygen and nutrients occur on the capillary level, 
capillary density and capillary blood flow are essential to accommodate intact neurovascular 
coupling.52 cSVD is associated with endothelial dysfunction.1, 53 When endothelial cell signalling 
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is disrupted, disruption of the capillary function occurs including disruption of vascular control. 
This may result in a disrupted blood flow and in capillary shunting through arteriolo-venu-
lar pathways. Capillary shunting leads to disrupted capillary patency and inadequate vascular 
exchange surface for oxygen and nutrients.17
Capillary dysfunction is a more recent hypothesis in the pathophysiology of cSVD. However, 
examining capillary function and neurovascular coupling is not straightforward. Many studies 
have looked into CBF in cSVD but CBF does not equal cerebral tissue perfusion. When CBF 
increases but the exchange surface does not increase proportionally, tissue perfusion remains 
the same or may even be reduced. Therefore, it may be more accurate to study the combination 
of capillary density (an indicator for capillary exchange surface) and (changes in) capillary 
blood flow as a measure for capillary function and neurovascular coupling. However, this is 
not yet possible in the human brain in vivo. As cSVD is considered to be part of systemic small 
vessel disease, other microvascular beds such as the sublingual circulation may be used to study 
capillary function in cSVD.54 
Sublingual microvascular imaging
Intravital microscopy can be used to examine microcirculation. This method has earlier been 
used to measure glycocalyx thickness in the sublingual microvessels. Glycocalyx is a carbohy-
drate-rich layer aligning the vascular endothelium and is considered to be essential in many 
endothelial functions including regulation of the vascular tone and permeability. We found a 
difference in glycocalyx thickness between patients with lacunar stroke and extensive WMH and 
healthy controls.55 Apart from the glycocalyx thickness, intravital microscopy can also be applied 
to measure capillary density and capillary flow dynamically. This technique may therefore pro-
vide more insight into the capillary function in patients with cSVD. Applying this technique 
directly to the cerebral capillaries is not possible, as it would require a craniectomy. However, 
as cSVD is considered a systemic endotheliopathy, we examined the sublingual microvessels 
in patients with cSVD.
GENERAL INTRODUCTION
 15
1
GENERAL AIM AND OBJECTIVES 
OF THIS THESIS 
The general aim of this thesis is to gain further insight into several pathophysiological mech-
anisms of cSVD, using various new quantitative imaging techniques including DCE-MRI, 
IVIM imaging and sublingual intravital microscopy. By using these techniques we aim to 
examine BBB dysfunction, microstructural and microvascular flow changes in the brain 
parenchyma, and capillary function, in patients with cSVD and in ageing controls. Moreover, 
we aim to determine the relationships between these measures and clinical and radiological 
markers associated with cSVD.
The general aim is addressed in several objectives:
1. To compare quantitative measures of BBB permeability, i.e. leakage rate and leakage 
volume, between patients with cSVD and normal ageing controls, using DCE-MRI 
(chapter 2).
2. To investigate the relationship between BBB permeability (i.e. leakage rate and leakage 
volume) and WMH volume, and between BBB permeability and cognition, in patients 
with cSVD and normal ageing controls (chapter 3). 
3. To examine whether IVIM MRI is a viable method to detect changes in microstruc-
ture and microvascular flow concomitantly, and how these measures relate to WMH 
volume, in patients with cSVD and normal ageing controls (chapter 4). 
4. To investigate the relationship between microstructure and cognition, and between 
microvascular flow and cognition, in patients with cSVD and ageing controls. In addi-
tion, we aim to examine the interaction between microstructure and microvascular 
flow in cognitive function (chapter 5).
5. To examine the capillary function by studying the dynamic relation between sub-
lingual capillary density and capillary blood flow in patients with cSVD and normal 
ageing controls (chapter 6).
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STUDY POPULATION
The study population consists of patients with clinically overt cSVD: first-ever lacunar stroke 
patients or patients with mild VCI due to presumed cSVD. Lacunar stroke patients were 
recruited from the Stroke Unit of the Maastricht University Medical Centre and Zuyderland 
Medical Centre, The Netherlands, in the period between April 2013 and December 2014. Lacu-
nar stroke was defined as an acute stroke syndrome with a compatible recent small subcortical 
infarct on clinical brain MRI. If no such lesion was visible on MRI, established clinical criteria 
for lacunar syndrome were used.56, 57 Patients with a potential cardiac embolic source or ipsi-
lateral carotid stenosis of ≥50% were excluded. Patients with mild VCI due to presumed cSVD 
were recruited from the outpatient clinic of the Department of Neurology and from the Memory 
Clinic of the Maastricht University Medical Centre, and Zuyderland Medical Centre. Criteria 
of mild VCI were met when patients had 1) subjective complaints of cognitive functioning, 2) 
objective cognitive impairment in at least one cognitive domain at neuropsychological testing, 
3) a Clinical Dementia Rating of ≤1 and a Mini Mental State Examination score of ≥20, and 4) 
vascular lesions on clinical brain MRI that suggest a link between the cognitive deficit and cSVD: 
moderate to severe WMH (Fazekas score deep WMH>1 and/or periventricular WMH>2), or 
mild WMH (Fazekas score deep WMH=1 and/or periventricular WMH=1-2) with lacunes 
and/or microbleeds. 
We also recruited age- and sex-matched controls from the outpatient clinic of the Department 
of Neurology. Controls did not have a history of overt cerebrovascular diseases or cognitive 
impairment. Most of them had lumbar radicular syndrome or peripheral neuropathies. 
Additional exclusion criteria for all participants include neurodegenerative diseases, multiple 
sclerosis, epilepsy, systemic inflammatory diseases, alcohol abuse, psychiatric disorders or use 
of medication that may influence the accuracy of neuropsychological testing, and the presence 
of a contra-indication for MRI (e.g. pacemaker, claustrophobia, or contrast allergy). 
All participants underwent structural brain MRI to quantify WMH volume, DCE-MRI to quan-
tify BBB leakage, IVIM imaging to quantify microstructural integrity and microvascular flow, 
sublingual intravital microscopy to measure capillary density and capillary flow, and extensive 
neuropsychological assessment to determine the cognitive function. 
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ABSTRACT
Objectives
As blood-brain barrier (BBB) dysfunction may occur in normal ageing but may also play a 
pivotal role in the pathophysiology of cerebral small vessel disease (cSVD), we used dynamic 
contrast-enhanced (DCE) MRI to quantify the rate and the spatial extent of BBB leakage in 
cSVD patients and age- and sex-matched controls to discern cSVD related BBB leakage from 
ageing related leakage. 
Methods
We performed structural brain MRI and DCE MRI in 80 clinically overt cSVD patients, and 
40 age- and sex-matched controls. Using the Patlak pharmacokinetic model, we calculated the 
leakage rate. The mean leakage rate and relative leakage volume were calculated using noise 
corrected histogram analysis. Leakage rate and leakage volume were compared between cSVD 
patients and controls, for the normal appearing white matter (NAWM), white matter hyperin-
tensities (WMH), cortical grey matter (CGM) and deep grey matter. 
Results
Multivariable linear regression analyses adjusting for age, sex and cardiovascular risk factors 
showed that the leakage volume of the NAWM, WMH and CGM was significantly larger in 
cSVD patients compared with controls. No significant difference was found for leakage rate in 
any of the tissue regions.
Conclusion
We demonstrated a larger tissue volume with subtle BBB leakage in cSVD patients than in 
controls. This was shown in the NAWM, WMH and CGM, supporting the generalized nature 
of cSVD.
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INTRODUCTION
Cerebral small vessel disease (cSVD) underlies debilitating clinical disorders including lacunar 
stroke and vascular cognitive impairment.1-3 The pathophysiology is still unclear but blood-brain 
barrier (BBB) dysfunction has been proposed as one of the mechanisms.2 
BBB dysfunction occurs in normal ageing but may also play a pivotal role in cSVD. Extravasation 
of blood components may cause local vascular changes and diffuse brain tissue damage.4-7 With 
the development of dynamic contrast-enhanced (DCE)-MRI, several studies aimed to measure 
BBB permeability in cSVD patients. Semi-quantitative contrast-enhanced studies described the 
prolonged MRI signal enhancement of a contrast agent in the white matter, and attributed this to 
increased BBB permeability in lacunar stroke patients.8,9 Moreover, BBB permeability in the white 
matter was found to be quantitatively increased in patients with vascular cognitive impairment.10 
To distinguish cSVD related BBB leakage from normal ageing related BBB breakdown, quantitative 
techniques are highly preferred. However, quantitative data of BBB permeability in cSVD patients 
are scarce and knowledge on the spatial extent of BBB leakage in cSVD is lacking.1 
Dual-time resolution DCE-MRI enables measurement of contrast agent in the microvascular 
blood space and detection of the extravasation of relatively low concentrations of a contrast agent 
through the BBB. By using DCE-MRI combined with pharmacokinetic modelling, we aim to 
provide accurate, quantitative data of BBB leakage rate and the spatial extent (volume) of BBB 
leakage in cSVD patients compared with a control group. To have a clinical spectrum linked to 
cSVD, we included patients with lacunar stroke and patients with vascular cognitive impairment. 
METHODS
Study population
We included clinically overt cSVD patients and age- and sex-matched controls. cSVD patients 
consist of consecutive first-ever lacunar stroke patients and patients with mild vascular cogni-
tive impairment (mVCI) who consented to participate in the study. Participants were included 
from the Maastricht University Medical Centre and Zuyderland Hospital, The Netherlands, 
between April 2013 and December 2014. Lacunar stroke patients were recruited from the 
Stroke Unit. Lacunar stroke was defined as an acute stroke syndrome with a compatible recent 
small subcortical infarct on brain MRI. If no such lesion was visible on imaging, established 
criteria for lacunar stroke syndrome were used.11, 12 Exclusion criteria include a potential car-
diac embolic source (e.g. atrial fibrillation), or symptomatic carotid stenosis of ≥50%.13 Stroke 
patients were included at least three months post-stroke to avoid acute stroke changes.14 mVCI 
patients were recruited from the outpatient clinic of the Department of Neurology and from 
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the Memory Clinic. Criteria of mVCI were met when patients had 1) subjective complaints of 
cognitive functioning, and 2) objective cognitive impairment in at least one cognitive domain 
at neuropsychological testing, and 3) a Clinical Dementia Rating of ≤1 and a Mini Mental State 
Examination score of ≥20, and 4) vascular lesions on brain MRI that suggest a link between 
the cognitive deficit and cSVD15: moderate to severe white matter hyperintensities (WHM; 
Fazekas score deep>1 and/or periventricular>2), or mild WMH (Fazekas score deep=1 and/or 
periventricular=2) combined with lacune(s) and/or microbleeds.16 
Age- and sex-matched controls were recruited from the outpatient clinic of the Department of 
Neurology. We included one control per two cSVD patients. Controls were defined as partici-
pants with no overt cerebrovascular diseases and no cognitive impairment. Most of them had 
lumbar radicular syndrome or peripheral neuropathies. Additional exclusion criteria for all 
participants include neurodegenerative diseases, multiple sclerosis, epilepsy, systemic inflam-
matory diseases, alcohol abuse, psychiatric disorders or use of medication that may influence 
the accuracy of neuropsychological testing, and the presence of a contra-indication for MRI 
(e.g. pacemaker, claustrophobia, or contrast allergy). 
Characteristics of all participants were recorded including age, sex, and the presence of car-
diovascular risk factors including hypertension (history of hypertension and/or use of blood 
pressure lowering drugs), hypercholesterolemia (history of hypercholesterolemia and/or use 
of statin), diabetes mellitus (history of diabetes mellitus or use of blood sugar lowering drugs), 
smoking (current smoking) and Body Mass Index (BMI: current weight of the subject by the 
square of the current length). 
Standard Protocol Approvals, Registrations, and Patient Consents
The Medical Ethics Committee of the Maastricht University Medical Centre approved the 
study. All participants were included after written informed consent. This study is registered on 
www.trialregister.nl (NTR number NTR3786).
Structural Magnetic Resonance Imaging
All participants underwent structural brain MR imaging (3.0 Tesla). A T1-weighted sequence 
and T2-weighted FLAIR sequence were used for anatomic reference and detection of white 
matter hyperintensities, respectively. MRI sequence parameters are in Supplementary Material.
DCE MRI
Dual-time resolution DCE-MRI consisted of two integrated dynamic sequences with different 
dynamic scan time (DST), the fast and the slow sequence.17 Both sequences were saturation 
recovery gradient recalled sequences with a flip angle of 10° for the excitation pulse and had 
a 90° non-selective saturation prepulse with a time delay (TD) of 120 ms. First, pre-contrast 
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scans of both sequences were acquired prior to bolus injection. Subsequently, the fast sequence 
was applied (DST 3.2 s, TR/TE = 5.6/2.5 ms, FOV: 256x200x50 mm3, voxel size of 2x2x5 mm, 
29 volumes, SENSE =2) during bolus injection. Hereafter, the slow sequence was performed 
(DST 30.5 s, TR/TE = 5.6/2.5 ms, FOV: 256x256x100 mm3, voxel size of 1x1x2 mm, 45 vol-
umes, SENSE=2). Both sequences were centred on the periventricular region. The contrast 
agent (Gadobutrol 1.0mmol/ml; 0.1 mmol/kg body weight, range 5-10 mmol per person) was 
injected in the antecubital vein at a rate of 3 ml/s using a power injector. To convert the contrast 
enhanced signal intensities to concentrations in tissue, T1-mapping18 was performed prior to 
contrast agent administration and dynamic imaging.
Brain segmentation 
Grey and white matter were segmented on the T1-weighted images using dedicated imag-
ing software (Freesurfer19). Subsequently, WMHs were segmented on the FLAIR image to 
differentiate between normal and abnormal appearing white matter using a semi-automated 
segmentation tool.20 Moreover, infarcts were visually identified and excluded from the WMHs. 
FLAIR and T1-weighted image were co-registered using FSL (v5.0)21 and the following tissue 
regions of interest (ROIs) were selected: normal appearing white matter (NAWM), WMHs, 
cortical grey matter (CGM) and deep grey matter (DGM). 
Pharmacokinetic modelling
The concentration of contrast agent in tissue was calculated by using the relative signal change 
and T1-mapping.18 The vascular input function was derived from the superior sagittal sinus.22 
To convert the signal intensity curve to concentration, a calibration curve was obtained from 
phantoms with various in vitro contrast agent concentrations. Subsequently, the graphical Patlak 
model was used to estimate the leakage rate in terms of the transfer constant Ki (min-1) and the 
blood plasma volume in terms of the fractional intravascular space (vP).23 
Ki and vP were obtained from the slope and intercept, respectively, of the Patlak plot. In this way, 
the concentration time-course of the extravasating contrast agent, i.e. leakage, was discerned 
from the intravascular concentration. The leakage rate Ki can be understood as the initial con-
centration increase per time unit (speed) in the tissue relative to the blood concentration. This 
rate is estimated from the increase of the tissue concentration over time from a pharmacokinetic 
model in which re-uptake of contrast agent by the blood, is neglected. 
Histogram analysis 
The Ki and vP were determined in a voxel-wise manner. For the Ki values a histogram was calculated 
for each ROI. The Ki histogram had positive, zero, and negative Ki values and appeared skewed 
towards more positive Ki values (Figure 1). In the case of subtle leakage, Ki values had an overlap 
with noise. The noise could be observed by the presence of negative values in the histogram. To 
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correct the leakage for noise, the positive noise distribution was estimated by mirroring the neg-
ative Ki value distribution and subtracting this from the original Ki distribution (Figure 1).17 This 
resulted in a histogram of (positive) Ki values reflecting the detectable leakage rates. Descriptive 
values from this (positive) histogram were derived: the mean Ki, by taking the average of Ki values, 
indicating the magnitude of the (detectable) leakage rate, and the fractional volume of leakage (vL) 
which was the remaining area under the histogram curve, representing the relative volume of leak-
age with respect to the tissue volume of interest. Note that vL is a volume measure and represents a 
conceptually different measure of the leakage, namely the spatial extent, whereas the leakage rate 
Ki is a magnitude measure. These calculations were performed for all ROIs. For the blood plasma 
volume, the mean value over each ROI was taken. For the purpose of conceptual clarity, we will use 
the term leakage rate (reflected in the transfer constant Ki) for the rate of contrast leakage across 
the vessel wall and leakage volume (reflected in vL) for the fractional volume of leaky brain tissue, 
as the two quantitative measures of BBB leakage. 
Figure 1. Histogram analysis
An overview of the noise estimation method using bar graphs. Here, the x-axis shows the leakage rate (Ki) 
and the y-axis the fraction (i.e. the percentage divided by 100) of brain tissue (voxels) with this leakage rate. In 
(A) a distribution of the leakage rate values are shown with positive, zero and negative values, which appears 
skewed towards more positive values. To estimate the noise distribution, the negative values are assumed to 
be noise. By mirroring these negative bins around zero, a total noise distribution (grey bins) was estimated 
(B). Subtracting this noise distribution (B, grey bins) from the original distribution (B, black bins) results in a 
(positive) leakage rate distribution corrected for noise (C, black bins). The leakage volume is calculated as the 
area under the bar graph of the leakage rate distribution corrected for noise (C, black bins).
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Statistical analysis
Independent Student t-test and chi-square test were used for comparing clinical characteristics 
between cSVD patients and controls. The leakage rate and leakage volume were examined and 
compared between cSVD patients and controls using univariable linear regression analysis, 
with mean leakage rate, leakage volume and blood plasma volume respectively, as dependent 
variable, and group (cSVD vs. controls) as independent variable. Subsequently, multivariable 
linear regression analysis was performed with age, sex, group (cSVD vs. controls) and cardio-
vascular risk factors as independent variables. This was performed for all ROIs. Similar analyses 
were performed for the blood plasma volume. Furthermore, we also compared the subgroups 
lacunar stroke and mVCI with regard to leakage rate and leakage volume using univariable and 
multivariable linear regression analysis adjusted for age, sex and cardiovascular risk factors. 
Statistical significance was inferred at p<0.05. We controlled for multiple testing according to 
the Benjamin-Hochberg procedure, using a false discovery rate of 0.10.24 All statistical analyses 
were performed using commercial software (SPSS 22). 
RESULTS
We included 80 patients with cSVD and 40 age- and sex-matched controls. We excluded 4 partic-
ipants due to unsuccessful imaging or image artefacts, leaving 77 cSVD patients (43 patients with 
lacunar stroke and 34 patients with mVCI) and 39 controls suitable for analysis. An example of a 
leakage map of a patient with cSVD is displayed in Figure 2. Clinical characteristics of these partici-
pants are presented in Table 1 (more data in Supplementary Material, Table I). Hypercholesterolemia 
and current smoking were significantly more prevalent in patients compared with controls. 
Table 2 provides an overview of the quantitative results and includes the comparison between 
the two groups. 
Leakage rate: univariable and multivariable linear regression analysis showed no significant 
differences for leakage rate between cSVD patients and controls in any of the ROIs. 
Leakage volume: univariable regression analysis showed a significantly higher leakage volume 
in the WMH and CGM of cSVD patients compared with controls. In addition, multivaria-
ble regression analysis showed a significantly higher leakage volume in cSVD patients in the 
NAWM, WMH and CGM. This higher leakage volume is mainly observed in the range of the 
low leakage rates (Figure 3).
Blood plasma volume: patients with cSVD showed a tendency of lower blood plasma volume 
values than controls in all tissue regions. However, these differences were not significant. 
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Figure 2. FLAIR image and leakage map
Example of a FLAIR image (A) and a leakage map (B) of one cSVD patient with extensive white matter hyper-
intensities and a lacunar infarct (arrow in A). The leakage is diffuse throughout the brain.
Table 1. Characteristics of cSVD patients and controls
cSVD patients
N=77
Controls
N=39
Age, years (SD) 70 (11) 69 (12)
Male (%) 46 (60) 23 (59)
Hypertension (%) 49 (64) 18 (46)
Hypercholesterolemia (%)* 50 (65) 13 (33)
Diabetes (%) 12 (16) 4 (10)
BMI kg/m2 (SD) 26 (4) 27 (3)
Smoking (%)* 19 (25) 3 (8)
BMI – body mass index 
*p<0.05 when comparing cSVD patients and controls
In the multivariable analyses, none of the cardiovascular risk factors showed consistent inde-
pendent association with BBB leakage, except for hypercholesterolemia, which is associated with 
a lower leakage volume in the NAWM, CGM and DGM (data not shown). 
Comparison between the two patient groups using univariable and multivariable analysis, 
showed no significant differences in leakage volume, and a higher leakage rate in the DGM 
and WMH in lacunar stroke patients compared with mVCI patients (Supplementary Material, 
Table II). 
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Figure 3. Leakage rate in cSVD patients and controls
Group average noise-corrected leakage rate histograms in the normal appearing white matter (A) and cortical 
grey matter (B) for patients with cSVD (black) and controls (grey). The x-axis shows the leakage rate (Ki), the 
y-axis represents the fraction (i.e. percentage divided by 100) of brain tissue with that leakage rate value. Note 
that patients reveal a higher leakage fraction of the relatively low leakage rate values. This results in a larger 
area under the curve: patients demonstrate a larger leakage volume.
Table 2. Leakage rate, leakage volume and blood plasma volume in cSVD patients and controls
cSVD
patients Controls
Univariable
β p-value
Multivariable
β p-value
NAWM Ki (10-3 min-1) 0.97 (0.04) 1.05 (0.05) -0.119 0.20 -1.960 0.05
vL (10-2) 37.4 (2.15) 31.4 (2.91) 0.151 0.11 0.261 0.01*
vp (10-2) 1.68 (0.10) 2.30 (0.45) -0.163 0.08 -0.156 0.13
WMH Ki (10-3 min-1) 0.85 (0.03) 0.87 (0.05) -0.042 0.66 -0.086 0.41
vL (10-2) 45.5 (2.31) 35.2 (3.00) 0.239 0.01* 0.329 0.001*
vp (10-2) 1.61 (0.14) 2.27 (0.34) -0.199 0.03 -0.184 0.07
CGM Ki (10-3 min-1) 1.43 (0.05) 1.49 (0.07) -0.071 0.45 -0.140 0.17
vL (10-2) 20.7 (1.56) 14.7 (1.76) 0.214 0.02* 0.313 0.002*
vp (10-2) 3.56 (0.19) 4.39 (0.53) -0.165 0.08 -0.162 0.12
DGM Ki (10-3 min-1) 1.06 (0.04) 1.11 (0.06) -0.070 0.45 -0.110 0.29
vL (10-2) 33.3 (2.14) 30.4 (3.61) 0.068 0.47 1.77 0.08
vp (10-2) 3.33 (0.20) 4.09 (0.57) -0.142 0.13 -0.121 0.25
Notation: mean (standard error)
NAWM – normal appearing white matter; WMH – white matter hyperintensities; DGM – deep grey matter; 
Ki – leakage rate; vL – leakage volume; vp – blood plasma volume. 
Multivariable linear regression analysis with Ki, vL and vp as dependent variable and age, sex, group and cardi-
ovascular risk factors as independent variables.
*p-values that remain statistically significant after multiple comparison correcting for the testing of 4 tissue 
regions of interest 
CHAPTER 2
30
DISCUSSION
In this study, we found that patients with cSVD exhibit a larger volume of subtle leakage in the 
NAWM, CGM and WMH compared with controls, whereas leakage rate did not differ. This 
finding indicates that spatial extent of leaky brain tissue is significantly larger in cSVD patients 
than controls. 
The current approach was tailored to measure very subtle BBB leakage rates with values towards 
or in the noise range. Therefore a dual-time resolution DCE-MRI technique was applied with 
two different time resolutions to adequately discern the early recirculation of the contrast agent 
from the later washout, a relatively long measurement time and a dedicated analysis method that 
corrected for the inherent noise. Introducing the concept of leakage volume, it appeared that 
the differences in leakage between patients with cSVD and controls manifested particularly in 
an increased spatial extent of very subtle leakage. Differences between patients with cSVD and 
controls manifested for the very low leakage rate values, which appeared more prominent in 
cSVD, and not the average of (locally) high leakage rate values (Figure 3). The values of these 
low leakage rates were in the order of the noise level, and could only be detected due to the 
methodological optimization (noise filtering). 
 
Our finding that cSVD patients have a larger tissue volume showing BBB leakage is in line with 
the assumption that cSVD is a disease with diffuse, endothelial damage.1 Although subtle, the 
endothelial failure was detectable and appears to extend to the white matter as well as CGM. 
cSVD was primarily considered a white matter disease but recent studies show that CGM is 
also involved.2,19,20 Our results are in accordance with these advanced insights and underline the 
importance of investigating both cortical and white matter involvement in cSVD. 
BBB leakage rate was not higher in patients with cSVD compared with controls. This may reflect 
the subtle nature of BBB dysfunction, which is supported by recent neuropathological studies 
which showed that markers associated with BBB integrity were reduced, but extravasation of 
large plasma proteins was not significantly increased in cSVD.25, 26 Apparently, BBB dysfunction 
is present but possibly, only small molecule leakage can be measured. 
In contrast to our finding, an earlier study showed stronger BBB leakage rates in the white matter 
of VCI patients compared with controls, using DCE-MRI and pharmacokinetic modelling.10 
However, their controls were not matched by age, nor were the results corrected for age, and 
the investigated group also included patients with cortical stroke. As ageing is thought to be 
associated with an increase of BBB permeability, the difference in age criteria of the control 
group may explain the different observations and underline the importance of age-matching.4, 
27 Furthermore, our finding that leakage rate does not differ between cSVD patients and age- 
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matched controls may suggest that changes in leakage rate are ageing related processes, and 
are not specifically cSVD related. Other studies showed an increased contrast enhancement in 
the white matter suggesting stronger leakage in lacunar stroke patients compared with cortical 
stroke patients, and with controls.8, 9 Objective comparisons with our study remain difficult, as 
control groups were different and/or these two previous studies used semi-quantitative analysis 
methods in which intravascular and extravascular enhancement were not separated and effects 
may either be due to leakage and/or volumetric changes in the microvasculature. In the current 
study, we set out to separate intravascular enhancement and BBB leakage by using the dual-time 
resolution scanning technique and adequate pharmacokinetic modelling. Recently, a longitu-
dinal study found that regions with BBB leakage show minimal overlap over time, alluding the 
dynamic nature of BBB leakage.28 We intend to perform longitudinal analyses in our cohort. 
We found that patients with cSVD had a lower (although not significantly) blood plasma volume in 
all brain regions compared with controls. As blood plasma volume is related to cerebral perfusion, 
this observation is in line with the hypothesis that cSVD is associated with a reduction of cerebral 
blood flow and/or loss of autoregulation, causing chronic, diffuse ischemia in the long run.2 Further 
in vivo studies are needed to confirm the link between hypoperfusion and BBB leakage in cSVD. 
We showed that hypercholesterolemia is significantly associated with a lower leakage volume. 
As nearly all participants who met our criteria for hypercholesterolemia also use statins, this 
may reflect the hypothesis that statins improve endothelial function and stabilize the BBB.2, 29
Leakage rate differed between lacunar stroke and mVCI patients. Although we presume that the 
underlying pathophysiology in both groups is cSVD, differences may exist. The lacunar stroke 
group may be a more homogenous cSVD group compared with mVCI group. Despite our selec-
tion criteria, it is possible that other pathophysiological processes such as amyloid angiopathy or 
Alzheimer’s pathology coexist in some of the mVCI patients, affecting our findings and causing 
the differences in leakage rate. 
Our study has several important strengths. Firstly, we used clearly defined in- and exclusion 
criteria for cSVD patients. This enabled us to have a well-represented spectrum of clinically overt 
cSVD patients. Secondly, the age- and sex-matched controls enabled us to make reliable compar-
isons between the groups. Thirdly, we optimized the MR protocol by using two MR sequences 
with two different temporal resolutions. Particularly the high temporal resolution during con-
trast injection enabled us to determine the intravascular component more accurately, which is 
a prerequisite for performing reliable pharmacokinetic modelling and specifically detecting the 
very subtle leakage.22 Fourthly, we applied pharmacokinetic modelling to provide quantitative 
data on BBB permeability for each voxel. This modelling is necessary for separating the leakage 
from intravascular contrast enhancement.23 
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A limitation of this study is that not the entire cerebrum was sampled during the fast sequence. 
However, the field of view covered important regions associated with small vessel disease pathol-
ogy including the periventricular white (and grey) matter.30 The accuracy and reproducibility of 
our method is yet to be determined. However, it has recently been shown that the Patlak model 
is most suitable for determining subtle leakage, and our leakage rate values are comparable with 
leakage rate values found using a similar protocol in patient groups with subtle leakage.27, 31 
 
Our study has provided more insight in BBB leakage in cSVD. It appears that BBB leakage is 
very subtle and more spatially extensive in cSVD patients compared with age- and sex-matched 
controls without clinically overt cerebrovascular diseases. This underscores the generalized 
nature of cSVD and fits to the conceptual idea of spatially diffuse microvascular endothelial 
failure. In addition, our study provides a quantitative method to examine the magnitude and 
the spatial extent of subtle BBB leakage, establishing grounds for future longitudinal studies 
and possibly an important step towards further clarifying the role of BBB dysfunction in the 
pathogenesis of cSVD. 
BLOOD-BRAIN BARRIER LEAKAGE IN CSVD
 33
2
SUPPLEMENTARY MATERIAL
Structural Magnetic Resonance Imaging
All participants underwent structural brain MR imaging on a 3.0 Tesla magnetic resonance 
scanner (Achieva TX, Philips Healthcare, Best, the Netherlands), employing a 32-element head 
coil suitable for parallel imaging. A T1-weighted sequence (TR/TI/TE = 8.3/800/3.8 ms; field of 
view (FOV) 256x256x160 mm3; 1.0 mm3 cubic voxel) and T2-weighted FLAIR sequence (TR/TI/
TE = 4800/1650/299 ms; FOV 250x256x180 mm3; 1.0 mm3 cubic voxel) was used for anatomic 
reference and detection of white matter hyperintensities, respectively. 
Table I. Characteristics of lacunar stroke and mild vascular cognitive impairment patients, and controls
LS
N=43
mVCI
N=34
Controls
N=39
Age, years (SD)* 66 (12) 75 (8) 69 (12)
Male (%) 29 (67) 17 (50) 23 (59)
Hypertension (%) 29 (67) 20 (59) 18 (46)
Hypercholesterolemia (%)* 35 (81) 15 (44) 13 (33)
Diabetes (%) 4 (9) 8 (24) 4 (10)
BMI kg/m2 (SD) 26 (4) 25 (4) 27 (3)
Smoking (%) 13 (30) 6 (18) 3 (8)
LS – lacunar stroke; mVCI – mild vascular cognitive impairment; BMI – body mass index
*p<0.05 when comparing LS and mVCI patients
Table II. Leakage rate and leakage volume in lacunar stroke patients and mild vascular cognitive impair-
ment patients
LS mVCI
Univariable
β p-value
Multivariable
β p-value
NAWM Ki (10-3 min-1) 1.01 (0.05) 0.93 (0.06) -0.121 0.29 -0.215 0.13
vL (10-2) 38.1 (2.80) 36.5 (3.39) -0.042 0.72 -0.053 0.72
WMH Ki (10-3 min-1) 0.89 (0.04) 0.79 (0.05) -0.180 0.12 -0.323 0.02
vL (10-2) 44.9 (2.94) 46.2 (3.71) 0.032 0.78 0.044 0.76
CGM Ki (10-3 min-1) 1.48 (0.07) 1.37 (0.07) -0.120 0.30 -0.143 0.31
vL (10-2) 20.2 (2.11) 21.2 (2.34) 0.036 0.76 0.039 0.78
DGM Ki (10-3 min-1) 1.16 (0.05) 0.93 (0.06) -0.312 0.01 -0.398 0.004
vL (10-2) 31.1 (2.86) 36.1 (3.21) 0.132 0.25 0.141 0.32
LS – lacunar stroke; mVCI – mild vascular cognitive impairment
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ABSTRACT
Objectives
Blood-brain barrier (BBB) leakage increases with age and is involved in the pathophysiology 
of cerebral small vessel disease (cSVD). We examined the relationship between BBB leakage 
and white matter hyperintensity (WMH) volume and cognition, in cSVD patients and healthy 
controls. 
Methods
Seventy-seven patients with clinically overt cSVD and thirty-nine age matched healthy con-
trols underwent dynamic contract-enhanced and structural brain MRI and neuropsychological 
assessment. We quantified BBB leakage volume and rate in normal appearing white matter 
(NAWM), WMH and cortical grey matter (CGM). 
Results
Larger leakage volume and lower leakage rate in WMH were associated with larger WMH 
volume in cSVD but not in controls. Higher leakage rate in NAWM was associated with lower 
scores on executive function and information processing speed in healthy controls, whereas no 
relation with cognition was found in cSVD patients.
Conclusion
Our findings support the involvement of BBB leakage in cSVD and ageing. They also suggest 
that the mechanism of cognitive dysfunction in cSVD is more complex and multifactorial in 
cSVD compared with normal ageing. 
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INTRODUCTION
Blood-brain barrier (BBB) permeability increases with age and dysfunction of the BBB is 
thought to be an important pathophysiological mechanism in cerebral small vessel disease 
(cSVD).1, 2 cSVD is an age and vascular risk factors related disorder of the small vessels of the 
brain, and can cause debilitating disorders including vascular cognitive impairment (VCI) and 
lacunar stroke.3 Several dynamic contrast-enhanced (DCE) MRI studies observed higher BBB 
leakage in patients with lacunar stroke and patients with VCI, compared with controls, either 
in terms of leakage rate or proportion of brain volume showing BBB leakage.4-7
Macroscopically visible lesions such as white matter hyperintensities (WMH) may occur with 
increasing age and in the absence of cerebral vascular diseases. However, WMH – especially 
when they are extensive – are also considered local end-stage phenomena of cSVD and form a 
surrogate marker of cSVD disease severity. It would be relevant to know whether BBB defects 
could be tracked as an early marker for cSVD. Although data are limited, higher BBB leakage has 
been associated with increasing WMH load in healthy older subjects.2, 8 In patients with cSVD, 
data are even scarcer. No association was found between BBB leakage and WMH volume in 
patients with VCI.9 In patients with mild stroke, BBB leakage in the NAWM directly surround-
ing the WMH was higher in patients with the largest WMH load.10 
 
Further, how BBB leakage relates to clinical measures such as cognition is essential for the 
understanding of the pathophysiology of cSVD. Patients with vascular dementia demonstrated 
higher BBB leakage compared with healthy controls.6 Recently, a study in lacunar stroke patients 
showed no cross-sectional associations between BBB leakage and cognition, but BBB leakage 
in the WMH was associated with lower cognitive score at one year follow up.10 Further data 
on this matter in cSVD patients are lacking. In normal ageing, the relationship between BBB 
leakage and the level of cognitive function has not yet been studied. 
In the present study, we aimed to determine the relationship between BBB leakage and 
WMH volume, and between BBB leakage and cognition in cSVD and in normal ageing 
controls. 
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METHODS
Patient population
Patients with clinically overt cSVD were eligible for inclusion in this present study: first-ever 
lacunar stroke patients or patients with mild vascular cognitive impairment (mVCI) due to 
presumed cSVD.7 Lacunar stroke patients were recruited from the Stroke Unit of the Maastricht 
University Medical Centre and Zuyderland Medical Centre, The Netherlands, in the period 
between April 2013 and December 2014. We defined lacunar stroke as an acute stroke syndrome 
with a compatible recent small subcortical infarct on clinical brain MRI. In cases in which no 
lesion was detected on MRI, we used established clinical criteria for lacunar syndrome.11, 12 
Patients were excluded when they had a potential cardiac embolic source (e.g. atrial fibrillation) 
or ipsilateral carotid stenosis of ≥50%. Lacunar stroke patients underwent the test batteries at 
least three months post-stroke in order to avoid acute stroke changes. Patients with mVCI due 
to presumed cSVD were recruited from the outpatient clinic of the Department of Neurology 
and from the Memory Clinic of the Maastricht University Medical Centre, and Zuyderland 
Medical Centre. Criteria of mVCI consisted of 1) subjective complaints of cognitive function-
ing, 2) objective cognitive impairment in at least one cognitive domain at neuropsychological 
testing, 3) a Clinical Dementia Rating of ≤1 and a Mini Mental State Examination score of ≥20, 
and 4) vascular lesions on clinical brain MRI that suggest a link between the cognitive deficit 
and cSVD13: moderate to severe WMH (Fazekas score deep WMH>1 and/or periventricular 
WMH>2), or mild WMH (Fazekas score deep WMH=1 and/or periventricular WMH=1-2) 
with lacunes and/or microbleeds.14
Furthermore, we included age- and sex-matched healthy controls from the outpatient clinic of 
the Department of Neurology. One control was included per two cSVD patients. Criteria for 
healthy controls: no history of overt cerebrovascular diseases and no cognitive impairment. 
Moreover, none of the participants (patients as well as controls) may have neurodegenerative 
diseases, multiple sclerosis, epilepsy, systemic inflammatory diseases, alcohol abuse, psychiatric 
disorders or use of medication that may influence the accuracy of neuropsychological testing, 
and the presence of a contra-indication for MRI (e.g. pacemaker, claustrophobia, or contrast 
allergy.7
We recorded characteristics including age, sex, educational level and the presence of cardiovas-
cular risk factors including hypertension (history of hypertension and/or use of blood pressure 
lowering drugs), hypercholesterolemia (history of hypercholesterolemia and/or use of statin), 
diabetes mellitus (history of diabetes mellitus or use of glucose lowering drugs), smoking (cur-
rent smoking) and Body Mass Index (BMI: weight divided by the square of length).
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The study gained approval of the Medical Ethical Committee of the Maastricht University 
Medical Centre. All participants gave written informed consent. The study is registered on 
www.trialregister.nl (NTR number NTR3786).
Magnetic Resonance Imaging
MRI was performed on a 3.0 Tesla magnetic resonance scanner (Achieva TX, Philips Health-
care, Best, the Netherlands), employing a 32-element head coil suitable for parallel imaging. 
Structural MRI included a T1-weighted sequence (TR/TI/TE = 8.3/800/3.8 ms; field of view 
(FOV) 256x256x160 mm3; 1.0 mm3 cubic voxel) and T2-weighted FLAIR sequence (TR/TI/
TE = 4800/1650/299 ms; FOV 250x256x180 mm3; 1.0 mm cubic voxel). These were used for 
anatomic reference and detection of WMH, respectively.7
Dual-time resolution DCE-MRI was composed by two integrated dynamic sequences with 
different dynamic scan time (DST), the fast and the slow sequence.7 Prior to bolus injection, 
pre-contrast scans of both sequences were acquired, followed by the fast sequence (DST 3.2 s, 
TR/TE = 5.6/2.5 ms, FOV: 256x200x50 mm3, voxel size of 2x2x5 mm, 29 volumes, SENSE =2) 
during bolus injection. This fast sequence was followed by the slow sequence (DST 30.5 s, TR/TE 
= 5.6/2.5 ms, FOV: 256x256x100 mm3, voxel size of 1x1x2 mm, 45 volumes, SENSE=2). Contrast 
agent (Gadobutrol; dose 0.1 mmol/kg body weight) was infused in the antecubital vein at a rate 
of 3 ml/s using a power injector. To convert the contrast enhanced signal intensities to concen-
trations in tissue, T1-mapping was performed prior to dynamic contrast-enhanced imaging.7, 15
Image processing 
Freesurfer was used to segment grey and white matter from the T1-weighted images.16 WMHs 
were delineated on the FLAIR image using a semi-automated segmentation tool.17 Infarcts and 
lacunes were visually identified and excluded from the WMHs. FLAIR and T1-weighted images 
were spatially co-registered (FSL version 5.0) and the following brain regions were selected: 
normal appearing white matter (NAWM), WMH, and cortical grey matter (CGM).18 The WMH 
volume was quantified and normalized to the intracranial volume.7
Pharmacokinetic modelling and histogram analysis
Blood signal in the superior sagittal sinus was used for the vascular input function to calculate 
the concentration in blood plasma.19 To avoid contamination of inflow artefacts, the concentra-
tion in blood plasma was calculated by using a calibration obtained from phantoms with various 
in vitro contrast agent concentrations. Then, the graphical Patlak model was used to estimate the 
leakage rate in terms of the transfer constant Ki (min-1) and the blood plasma volume in terms 
of the fractional intravascular space vP.20 
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We determined Ki and vP from the Patlak plot and discerned the concentration time-course of the 
extravasating contrast agent, i.e. leakage, from the intravascular concentration. Ki is the leakage rate 
is determined from the increase of the tissue concentration over time from a pharmacokinetic model. 
Here, the return of contrast agent to the blood is neglected in the time period of the measurement. 
Ki and vP were determined for each voxel and a histogram was obtained for the Ki values. We 
corrected for noise by subtracting the negative Ki value from the original Ki distribution, result-
ing in a histogram reflecting the detectable leakage rates. Quantitative BBB leakage measures 
were obtained using this histogram: mean Ki, indicating the magnitude of the leakage rate, and 
vL which was the remaining area under the histogram curve, representing the fractional volume 
of leaky brain tissue (i.e. the spatial extent of leaky brain tissue).7 
Neuropsychological assessment
Extensive neuropsychological testing was performed and covered three main cognitive domains.7 
Tests assessing the memory domain included the Rey Auditory Verbal Learning Test (immedi-
ate recall, delayed recall, delayed recognition) and the Digit Span Forward. Tests assessing the 
executive function domain included the Stroop Colour-Word Test interference score (time of 
part 3 minus mean time of part 1 and 2), Trail Making Test interference score (time of part B 
minus time of part A), Category (animals and professions) and Letter Fluency, Letter-Number 
Sequencing and Digit Span Backward. Information processing speed was determined using the 
Symbol Substitution-Coding, Trail Making Test part A and Stroop Colour-Word Test parts 1 and 
2. Z-scores were calculated for each test: the difference between the individual raw score and the 
sample mean (i.e. the sample mean of the cSVD group for individuals of the cSVD group, and 
the sample mean of the control group for individuals of the control group) was divided by the 
sample SD. We calculated the compound domain scores for each participant by averaging the 
z-scores within each domain, and an overall cognition compound score was calculated taking 
the average of the three domain compound scores. The Hamilton Anxiety and Depression Scale 
test (range 0-42) was used to record depression and anxiety symptoms.7
Statistical analysis
We examined the relationship between vL, Ki in different brain regions (NAMW, WMH and 
CGM) and normalized WMH volume, first using univariable linear regression analysis and 
then multivariable linear regression analysis correcting for age and sex. Subsequently, we exam-
ined the relationship between vL and Ki in the different brain regions (independent variables) 
and the cognitive performance in three cognitive domains as continuous variables (dependent 
variables), using univariable and multivariable linear regression with correction for age, sex, 
educational level and Hamilton Anxiety and Depression Score. All analyses were performed 
in cSVD patients and healthy controls. Statistical analysis was performed using commercial 
software (SPSS 22.0); p<0.05 was considered statistically significant. 
BLOOD-BRAIN BARRIER LEAKAGE, WMH VOLUME AND COGNITION
 43
3
RESULTS
Eighty patients with cSVD (44 lacunar stroke patients and 36 mVCI patients) and forty healthy 
controls underwent MR imaging and neuropsychological assessment. Three patients (one with 
lacunar stroke and two with mVCI) and one control were excluded for data analysis due to 
imaging complications or imaging artefacts. Characteristics of the seventy-seven patients and 
thirty-nine controls included for analysis are shown in Table 1. For cognitive scores on all indi-
vidual tests, see Supplementary Material.
BBB leakage and WMH volume: In patients with cSVD, higher vL and lower Ki in WMH was 
significantly associated with a larger WMH volume (Table 2). These associations remained 
significant after correcting for age and sex. In the NAWM or CGM, vL nor Ki were associated 
with WMH volume. In the healthy control group, no significant association was found between 
BBB leakage in any of the regions and WMH volume (Table 2). After additional correcting for 
smoking, the results did not change substantially.
BBB leakage and cognitive function: in cSVD patients, no significant associations were found 
between vL or Ki and the cognitive domains overall cognition, executive function, information 
processing speed and memory, in univariable (Table 3) and multivariable analysis correcting 
for age, sex, educational level and Hamilton Anxiety and Depression Score. In healthy controls, 
higher Ki in the NAWM and in the WMH was significantly associated with lower scores in 
cognitive domains executive function and information processing speed, and higher Ki in the 
CGM was significantly associated with lower scores in the cognitive domain memory (Table 4). 
After correcting for age, sex, educational level and Hamilton Anxiety and Depression Score, the 
association between Ki in the NAWM and executive function and information processing speed 
remained significant (β=-0.280 p=0.03 and β=-0.261 p=0.02 respectively).
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Table 1. Characteristics of cSVD patients and healthy controls
cSVD patients
N=77
Controls
N=39 p-value 
Age, years (SD) 70 (11) 69 (12) 0.58
Male (%) 46 (60) 23 (59) 0.94
Educational level 0.58
   Low 35 (45) 13 (33)
   Average 27 (35) 20 (51)
   High 15 (20) 6 (15)
Hypertension (%) 49 (64) 18 (46) 0.07
Hypercholesterolemia (%) 50 (65) 13 (33) 0.001
Diabetes (%) 12 (16) 4 (10) 0.43
BMI kg/m2 (SD) 26 (4) 27 (3) 0.07
Smoking (%) 19 (25) 3 (8) 0.03
WMH volume (SE) 0.014 (0.002) 0.005 (0.002) <0.001
Ki (10-3 min-1)
   NAWM (SE)
   WMH (SE)
   CGM (SE)
0.97 (0.04)
0.85 (0.03)
1.43 (0.05)
1.05 (0.05)
0.87 (0.05)
1.49 (0.07)
0.20
0.66
0.45
vL (10-2)
   NAWM (SE)
   WMH (SE)
   CGM (SE)
37.4 (2.15)
45.5 (2.31)
20.7 (1.56)
31.4 (2.91)
35.2 (3.01)
14.7 (1.76)
0.11
0.01
0.01
WMH volume – WHM volume normalized to intracranial volume; BMI – body mass index; Ki – leakage rate; 
vL – leakage volume; NAWM – normal appearing white matter; WMH – white matter hyperintensities
Table 2. Association between WMH volume and vL and Ki, for NAWM, WMH and CGM, in cSVD patients 
and healthy controls, uncorrected and corrected for age and sex
cSVD Controls
Univariable Multivariable Univariable Multivariable
vL β p-value β p-value β p-value β p-value
NAWM 0.079 0.49 0.092 0.39 0.009 0.96 -0.002 0.99
WMH 0.268 0.02 0.267 0.01 0.184 0.26 0.123 0.45
CGM 0.154 0.18 0.111 0.30 0.097 0.56 0.039 0.81
Ki β p-value β p-value β p-value β p-value
NAWM -0.157 0.17 -0.174 0.10 0.069 0.68 0.048 0.77
WMH -0.267 0.02 -0.264 0.01 0.159 0.33 0.065 0.70
CGM -0.223 0.05 -0.185 0.08 0.115 0.49 0.178 0.28
vL – leakage volume; Ki – leakage rate; NAWM – normal appearing white matter; WMH – white matter hyper-
intensities; CGM – cortical grey matter 
β values represent standardized regression coefficients. 
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Table 3. Association between cognition and vL and Ki, for NAWM, WMH and CGM, in cSVD patients, 
uncorrected
Overall Executive Speed Memory
vL β p-value β p-value β p-value β p-value
NAWM 0.108 0.35 0.118 0.31 0.074 0.52 0.090 0.44
WMH 0.034 0.77 0.071 0.54 -0.006 0.96 0.029 0.80
CGM -0,028 0.81 -0.008 0.95 -0.036 0.75 -0.025 0.83
Ki β p-value β p-value β p-value β p-value
NAWM 0.019 0.87 0.132 0.25 -0.050 0.67 -0.020 0.86
WMH 0.097 0.40 0.172 0.14 0.010 0.93 0.081 0.49
CGM 0.039 0.73 0.091 0.43 0.014 0.91 0.001 0.99
Overall – overall cognitive function; Executive – executive function; Speed – information processing speed; 
vL – leakage volume; Ki – leakage rate; NAWM – normal appearing white matter; WMH – white matter hyper-
intensities; CGM – cortical grey matter
β values represent standardized regression coefficients.
Table 4. Association between cognition and vL and Ki, for NAWM, WMH and CGM, in healthy controls, 
uncorrected
Overall Executive Speed Memory
vL β p-value β p-value β p-value β p-value
NAWM 0.000 1 0.096 0.56 0.021 0.90 -0.108 0.51
WMH -0.094 0.57 0.020 0.91 -0.065 0.69 -0.192 0.24
CGM -0.166 0.31 -0.67 0.68 -0.136 0.41 -0.226 0.17
Ki β p-value β p-value β p-value β p-value
NAWM -0.237 0.15 -0.326 0.04* -0.339  0.04* 0.029 0.86
WMH -0.304 0.06 -0.366 0.02 -0.340 0.03 -0.105 0.52
CGM 0.204 0.21 0.051 0.31 0.143 0.39 0.333 0.04
Overall – overall cognitive function; Executive – executive function; Speed – information processing speed; 
vL – leakage volume; Ki – leakage rate; NAWM – normal appearing white matter; WMH – white matter hyper-
intensities; CGM – cortical grey matter
β values represent standardized regression coefficients.
*p<0.05 after correcting for age, sex, educational level and Hamilton Anxiety and Depression Score
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DISCUSSION
In this study on patients with clinically overt cSVD and age- and sex-matched healthy con-
trols, we examined the association between BBB leakage and cognitive performance as well 
as WMH volume. We showed that in cSVD patients, larger WMH volume was associated 
with larger (fractional) leakage volume and lower leakage rate in the WMH. Furthermore, 
we found that in healthy controls, higher leakage rate in the NAWM is associated with lower 
cognitive scores on executive function and information processing speed, whereas no relation 
was found with any of the cognitive domains in cSVD patients. 
BBB leakage is considered to play a pivotal role in the pathophysiological mechanisms of 
cSVD.21 Our results support this hypothesis by showing that with a larger WMH volume 
(which can be considered a marker for disease severity), more leakage in terms of a larger 
fractional leaking volume was present within these WMH. One could argue that more BBB 
leakage in the WMH is simply the result of tissue damage, instead of a preceding step in the 
occurrence of WMH. Longitudinal studies are needed to unravel a possible cause-conse-
quence relationship between BBB leakage and WMH volume.
The finding that lower leakage rate in WMH was associated with a larger WMH volume 
was unexpected. This observation might be related to a decreased perfusion in the WMH.22 
However, further studies into this subject are needed. 
It has been shown that in cSVD patients, the NAWM shows microstructural and BBB changes, 
suggestive for early pathological changes.7, 23 In the current study, we did not find an associa-
tion between BBB leakage in the NAWM and the severity of cSVD in terms of WMH volume. 
It is possible that leakage in the NAWM precedes development of visible WMH and therefore, 
no association can be detected between NAWM leakage and the current volume of WMH. 
Longitudinal studies can provide adequate insights in the temporal relationship between BBB 
leakage in the NAWM and occurrence of WMH. 
Other studies also investigated the association between BBB leakage in the white matter and WMH 
severity. A DCE-MRI study in patients with lacunar stroke used contrast enhancement as a semi-quan-
titative measure for BBB leakage and showed that contrast-enhancement in the NAWM but not in 
the WMH was correlated with the visual scoring grade of WMH.5 Yet, another study in patients 
with VCI did not find an association between WMH load and BBB leakage in the white matter, but 
they did not distinguish between NAWM and WMH.9 A recent study in stroke patients showed that 
BBB leakage in both NAWM and WMH increased with WMH load but only in young patients with 
cSVD.24 These inconsistent results reflect our still incomplete understanding of the mechanism of 
cSVD and the non-uniform state of development of BBB leakage measurement methods.
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We found no significant association between BBB leakage and WMH volume in healthy con-
trols, which differs from earlier findings.8 This may be due to the low presence of WMH in the 
control group. It may also be due to the differences in methodology: previous studies compared 
BBB leakage between groups with limited and extended WMH whilst our study examined the 
linear relationship between BBB leakage and WMH volume. Moreover, previous studies used 
biochemical methods or imaging techniques that differ from our DCE-MRI measurement. 
We found no association between BBB leakage and cognition in cSVD patients. This is consistent 
with earlier cross-sectional findings.10 We did find an association between cognitive function 
and BBB leakage in healthy controls. This may indicate that BBB leakage is related to cognitive 
dysfunction in normal ageing but no longer has a determining role in the cognitive functioning 
in cSVD due to dominant roles of more severe, vascular and parenchymal changes seen in cSVD. 
An association, if present, may be cofounded by other mechanisms such as lacunar infarcts and 
changes in cerebral perfusion and vasoreactivity. 
This study has several strengths. Firstly, we included a well-represented spectrum of patients 
with clinically overt cSVD, with different stages of disease severity, and also examined age- 
and sex- matched healthy controls. Although the patients had different clinical features, the 
underlying small vessel pathology is presumed to be the same. We used clear in- and exclusion 
criteria and tried to include a population with cSVD pathology with as little concurrent diseases 
that may influence the BBB permeability as possible. Secondly, we have examined both leakage 
volume and leakage rate. Although leakage volume is a relatively new measure, we previously 
found that leakage volume is a measure that differentiates cSVD patients from age- and sex-
matched controls, suggesting that leakage volume may be an equally important or perhaps even 
a more sensitive measure for BBB leakage than leakage rate.7 Moreover, recent studies have 
shown that the method we used is suitable for determining subtle leakage, and our leakage rate 
values are comparable with leakage rate values found in earlier studies.25, 26 Thirdly, by using 
quantitative measures for BBB leakage instead of earlier used semi-quantitative measures such 
as contrast enhancement, we could separate the filling of blood vessels with contrast material 
from leakage and examine the direct relationship between BBB leakage and WMH volume and 
cognition. This enables future analysis and comparison with other quantitative data, and with 
longitudinal data.
It is plausible that BBB leakage and cognitive function or WMH volume are associated in a 
time-related manner. The cross-sectional nature of our study may therefore be insufficient to 
detect such associations and may therefore be considered a limitation. Another limitation may 
be our relative small size of our healthy control group. However, despite this, we found signifi-
cant associations between BBB leakage and cognition in this group.
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In this study, we have presented quantitative data on the relation between BBB leakage and 
cognitive function and WMH volume in cSVD and normal ageing. A larger WMH volume is 
associated with a larger leakage volume within these WMH in cSVD. We could not demonstrate 
a relation between BBB leakage and cognitive function in cSVD but we did find such a rela-
tionship in normal ageing. Larger and longitudinal studies are desirable to gain further insight 
in the complex relationship between BBB leakage and the development of WMH and onset of 
cognitive dysfunction in cSVD and ageing.
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ABSTRACT
Objectives
Cerebral small vessel disease (cSVD) is associated with microvascular and parenchymal altera-
tions. Intravoxel incoherent motion (IVIM) MRI has been proposed to simultaneously measure 
both the microvascular perfusion and parenchymal diffusivity. This study aimed to evaluate the 
application of IVIM in cSVD to assess the microvasculature and parenchymal microstructure. 
Methods 
Seventy-three patients with cSVD (age 70±11y) and thirty-nine controls (age 69±12y) under-
went IVIM imaging (3T). Group differences of the perfusion volume fraction f and the 
parenchymal diffusivity D were investigated using multivariable linear regression accounted 
for age, sex and cardiovascular factors. To examine the relation between the IVIM measures 
and the disease severity on structural MRI, white matter hyperintensity (WMH) load served as 
surrogate measure of the disease severity. 
Results 
Patients had a larger f (p<0.024) in the normal appearing white matter (NAWM) than controls. 
Higher D (p<0.031) was also observed for patients compared with controls in the NAWM and 
grey matter. Both f (p<0.024) and D (p<0.001) in the NAWM and grey matter increased with 
WMH load. 
Conclusion
The increased diffusivity reflects the predicted microstructural tissue impairment in cSVD. 
Unexpectedly, an increased perfusion volume fraction was observed in patients. Future studies 
are needed to reveal the precise nature of the increased perfusion volume fraction. IVIM imag-
ing showed that the increases of f and D in cSVD were both related to disease severity, which 
suggests the potential of IVIM imaging to provide a surrogate marker for the progression of 
cSVD.
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INTRODUCTION
Age and vascular risk factor related cerebral small vessel disease (cSVD) is a common micro-
vascular pathology underlying burdensome diseases like lacunar stroke and vascular cognitive 
impairment.1-3 Alterations in the parenchyma have been described in cSVD as structural MRI 
abnormalities like lacunes, white matter hyperintensities, microbleeds and enlarged perivascular 
spaces (PVS).4 However, little is known about the precursors of these alterations, although MRI 
has provided some insight in this. Using perfusion MRI, hypoperfusion was found for the white 
matter in patients with cSVD.5, 6 Diffusion weighted imaging studies have provided indications 
that the loss of microstructural integrity in the white matter may be associated with cSVD.7-9 
Parallel data of the microvasculature and the parenchyma in the same patient group are lacking. 
More pathophysiological insights may be obtained by evaluating both structures concurrently 
and by linking them together. 
Intravoxel incoherent motion (IVIM) imaging is a non-invasive MRI technique that proposes 
to simultaneously measure such microvascular and parenchymal microstructural tissue proper-
ties.10 In contrast to conventional diffusion weighted techniques, where the microvasular signal 
confounds the parenchymal signal, it is assumed that IVIM can separate the MRI effects of the 
microvasculature and parenchyma. Promising results of IVIM in various clinical applications 
(e.g. oncology (tumor staging) and neuroimaging (management of cerebral infarction)) have 
been shown.11 The purpose of the present study was to investigate the applicability of IVIM in 
cSVD by assessing the microvasculature and parenchymal microstructure. 
METHODS
Study Population 
Between April 2013 and December 2014, 83 patients with clinically manifest cSVD and 40 
healthy controls were included. Participants were included from the Maastricht University Med-
ical Centre and Zuyderland Medical Centre, The Netherlands. Clinically manifest cSVD was 
defined as the occurrence of a recent lacunar stroke or the diagnosis of mild vascular cognitive 
impairment due to cSVD. Patients with lacunar stroke (n=44) had a first-ever acute lacunar 
syndrome with a compatible recent small subcortical infarct on brain MRI.12 If no such lesion 
was visible on imaging, established clinical criteria for lacunar syndrome were used (Supple-
mentary Material 1.1).13 Exclusion criteria for these patients include a potential cardiac embolic 
source (e.g. atrial fibrillation), or stenosis of ≥50% of one or both internal carotid arteries. 
Patients were included 3 months after the acute stroke to avoid acute stroke phase changes. 
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Patients with mild vascular cognitive impairment (mVCI) (n=39) had subjective cognitive 
complaints, failure in one or more cognitive domains determined by neuropsychological assess-
ment, and extensive MRI abnormalities associated with cSVD, i.e. white matter hyperintensities 
(WMHs) Fazekas score 3 or Fazekas score 2 or 3, and/or with microbleeds, and/or lacunes and 
no other apparent cause for the cognitive deficits.14 Furthermore, participants in whom a neuro-
degenerative disease other than vascular cognitive impairment was suspected (e.g. Alzheimer’s 
disease), with another neurological or psychiatric disease interfering with cognitive testing or 
with severe cognitive impairment defined as Mini Mental State Examination ≤20 and/or Clinical 
Dementia Rating ≥1, were excluded.
Controls (n=40) were stroke-free and had back pain or peripheral neuropathies without (sub-
jective) cognitive failures. Controls were matched on age and sex. 
All participants with a history of cerebrovascular disease, or other diseases of the central 
nervous system or with MRI contraindications were excluded. Baseline characteristics were 
recorded, including age, sex, education15, and cardiovascular factors such as hypertension 
(history of hypertension/antihypertensive medicine (including calcium antagonists)), hyper-
cholesterolemia (history of hypercholesterolemia/statin), diabetes (history of diabetes/ diabetes 
medication), current smoking and body mass index (BMI).
Standard protocol approvals, registrations and patient consents
This is a retrospective study and has been approved by the Medical Ethics Committee of Maas-
tricht University Medical Centre. All participants were included after given written informed 
consent was obtained. 
Image acquisition
Patients underwent brain imaging on a 3.0 Tesla MR scanner (Achieva TX, Philips Health-
care, Best, the Netherlands) using a 32-element head coil suitable for parallel imaging. 
For anatomical segmentation a T1-weighted sequence (TR/TI/TE=8.3/800/3.8 ms; FOV 
256x256x160 mm3; 1.0 mm3 isotropic voxel) and a T2-weighted FLAIR sequence (TR/TI/
TE=4800/1650/299 ms; FOV 256x256x180 mm3; 1.0 mm isotropic voxel) were performed 
respectively. 
IVIM imaging was conducted as described before.16 In brief, a Stejskal-Tanner diffusion weighted 
(DW) single shot spin-echo echo-planar imaging (EPI) pulse sequence (TR/TE=6800/84 ms; 
FOV 221x269x139 mm3; 2.4 mm isotropic voxel; acquisition time 5:13 minutes) was used. To 
minimize the signal contamination of CSF, an inversion pulse (TI=2230 ms) was given prior 
to the DW sequence.17 Fifteen DW images were acquired in the anterior-posterior direction 
using multiple diffusion sensitive b-values (0, 5, 7, 10, 15, 20, 30, 40, 50, 60, 100, 200, 400, 700, 
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and 1000 s/mm2). To increase the signal-to-noise ratio (SNR) (Supplementary Material 1.2) at 
high b -values the number of signal averages for the highest two b-values were two and three, 
instead of one, respectively. 
Image analysis 
The regions of interest (ROIs) were: the normal appearing white matter (NAWM), WMHs, deep 
grey matter (DGM) and the cortex. All ROIs were automatically segmented on T1-weighted 
images (Freesurfer software18 and FSL (v5.0)19). The WMHs were automatically segmented20 
on FLAIR images and visually checked under supervision of vascular neurologists, who also 
identified and excluded infarcts and scored PVS (Supplementary Material 1.3). The WMH load 
was calculated by normalizing the WMH volume to the intracranial volume. 
IVIM analysis
Preprocessing of the IVIM images has been described previously16 and consisted of distortion 
corrections (EPI and eddy current distortions) and head displacements (ExploreDTI v.4.8.3).21 
Hereafter, the images were registered to the corresponding T1-weighted image and spatially 
smoothed with a 3 mm full-width-at-half-maximum Gaussian kernel. The SNR at b = 1000 s/
mm2 was 4522 (Supplementary Material 1.2), which is larger than the minimum value (i.e. 30) 
recommended for accurate IVIM estimation.23
The diffusion-attenuation curve is approximated with a two-compartment diffusion model10: 
𝑆𝑆(𝑏𝑏)
𝑆𝑆(0) = (1 − 𝑓𝑓)𝑒𝑒
+,- + 𝑓𝑓𝑒𝑒+,(-∗0-)	 [1]
where S(b) is the signal intensity at b-value b, f the perfusion volume fraction, D the parenchymal 
diffusivity and D* the pseudodiffusion coefficient. The IVIM model considers the presence of a 
vascular and non-vascular compartment. The vascular part embodies the fast water motion in 
blood flowing into a network of small vessels, which has an architecture with many microvessel 
orientations. This gives rise to the pseudodiffusion coefficient, hereafter called intravascular 
diffusivity D*, and the perfusion volume fraction f. The perfusion related measure f∙D* was 
obtained by taking the product f∙D*. The non-vascular compartment is described by the water 
diffusion in the parenchymal microstructure represented by the slower parenchymal diffusivity 
D. To account for the CSF suppression and differences in relaxation time of blood and tissue, a 
modified IVIM model17 was employed (Supplementary Material 1.4). 
Model fitting was performed on a voxel-by-voxel basis using a two-step method24 (Sup-
plementary Material 1.5). This yields the IVIM measures (f, D*, f∙D* and D), which were 
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averaged over each ROI. The analysis accounted for the goodness of fit of the model (Sup-
plementary Material 1.5). 
Statistical analysis 
To examine differences between cSVD patients and controls, independent Student’s t-test and χ2 
test were used where appropriate. The differences in IVIM measures between cSVD patients and 
controls were analysed with an independent Student’s t-test and multivariable linear regression 
analysis corrected for age, sex and cardiovascular factors. In addition, differences were tested 
between patients with lacunar stroke and mVCI. To account for multiple comparisons a false 
discovery rate of 10% was applied.25
To investigate the relation between IVIM measures and disease severity on MRI, the WMH 
load was used as the dependent variable in linear regression. Both univariable and multivari-
able analyses with age, sex and cardiovascular factors were performed. This was conducted in 
patients, only for the IVIM measures that differed between patients and controls. Significance 
was inferred for p<0.05. All statistical analyses were performed using SPSS (version 22, IBM 
Corp., USA). 
RESULTS
For this study 73 patients with cSVD (40 patients with lacunar stroke and 33 patients with mild 
vascular cognitive impairment), and 39 controls were suitable for analysis. Participants showing 
image artefacts and image processing complications (n=11) were excluded (Supplementary 
Material 2.1). Table 1 lists the characteristics of the participants. Patients and controls were 
well matched on age and sex. Patients were more often smokers, suffered more from hypercho-
lesterolemia and had a lower BMI than controls. They also had a higher WMH load and more 
enlarged PVS in the basal ganglia. In Supplementary Material, Table I characteristics of patients 
with lacunar stroke and mVCI are shown. Patients with mVCI were older, suffered more from 
hypercholesterolemia and had a higher WMH load than those with lacunar stroke. 
IVIM maps of a patient with cSVD and a control can be appreciated in Figure 1. Table 2 shows 
the results of the perfusion volume fraction f and parenchymal diffusivity D in various ROIs. 
Patients have significantly higher perfusion volume fraction f than controls in all ROIs except in 
the WMHs. This difference remained significant after adjusting for age, sex and cardiovascular 
factors in the NAWM and DGM. Results of additional correction for medication and the extent 
of PVS can be found in Supplementary Material 1.3 and 2.2, respectively.
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Table 1. Baseline characteristics of patients with cSVD and controls
cSVD Controls p-value
(N=73) (N=39)
Age, y, mean(SD) 70(11) 69(12) 0.49
Male, N(%) 43(59) 23(59) 0.99
Hypertension, N(%) 46(42) 18(46) 0.09
Hypercholesterolemia, N(%) 47(64) 13(33) <0.01
Diabetes Mellitus, N(%) 12(16) 4(10) 0.57
Smoking, N(%) 18(25) 3(7.7) 0.04
Body mass index, mean(SD) 25(3.9) 27(3.5) 0.04
Educationa 0.26
   High, N(%) 13(18) 6(15)
   Moderate, N(%) 26(36) 20(51)
   Low, N(%) 34(47) 13(33)
Calcium antagonists intake N(%) 14(19) 4(10) 0.29
WMH load, mean (SD)x10-3 14(15) 5.0(9.8) <0.001
Presence of severe PVSb
   Centrum semiovale N(%) 30(48) 13(37) 0.32
   Basal ganglia N(%) 17(27) 2(5.1) 0.02
WMH – white matter hyperintensities; PVS – perivascular spaces
a Education level: low – finished high school or lower; moderate – finished intermediate vocational education; 
high – finished university degree
b These values represent participants with more than 25 PVS (Supplementary Material 1.3)
Figure 1. FLAIR image and IVIM maps of f and D
	
Example of a FLAIR image (left) and IVIM maps of the perfusion volume fraction f (centre) and parenchymal 
diffusivity D (right) for a patient with cSVD. The white arrows in the images indicate tissue with high values 
of perfusion volume fraction f and parenchymal diffusivity D, which appears normal on the FLAIR image. 
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Higher parenchymal diffusivity D was found in all ROIs for patients compared with controls. 
Parenchymal diffusivity D remained higher for patients after adjusting for age, sex and cardi-
ovascular factors. 
The results for the intravascular diffusivity D* and perfusion-related measure f∙D* are provided 
in Supplementary Material, Table II. No significant differences between the two groups were 
found for the intravascular diffusivity D* or the perfusion-related measure f∙D*.
Comparison between patients with lacunar stroke and mVCI are shown in Supplementary 
Material, Table III and IV. Patient with mVCI had higher perfusion volume fraction f (p=0.01), 
intravascular diffusivity D* (p=0.02) and perfusion-related measure f·D* (p<0.01) than patients 
with lacunar stroke in the DGM using univariable linear regression. Furthermore, higher paren-
chymal diffusivity D was observed in the NAWM for patients with mVCI than with lacunar 
stroke. However, when adjusting for cardiovascular risk factors and multiple comparisons, none 
of these differences remained significant. 
Table 2. Perfusion volume fraction f and parenchymal diffusivity D of patients and controls
cSVD (N=73)
Controls
(N=39)
Model 1a
ΔMean(95% CI)d p-value 
Model 2b
β(95% CI)e p-value  R2
Perfusion volume fraction fx10-2 (SE) 
NAWM 2.31(0.03) 2.21(0.03) 0.11(0.03, 0.20) 0.011c 0.48(0.08, 0.88) 0.020c 0.197
DGM 2.95(0.04) 2.69(0.05) 0.26(0.12, 0.39) <0.001c 0.68(0.29, 1.07) 0.001c 0.247
Cortex 2.53(0.04) 2.40(0.04) 0.14(0.02, 0.26) 0.024c 0.39(-0.02, 0.79) 0.060 0.184
WMHs 3.21(0.04) 3.03(0.09) 0.19(0.02, 0.39) 0.076 0.38(-0.03, 0.78) 0.068 0.158
Parenchymal diffusivity Dx10-4 (SE) mm2/s
NAWM 7.35(0.04) 7.15(0.05) 0.20(0.08, 0.32) 0.002c 0.56(0.18, 0.93) 0.004c 0.325
DGM 7.77(0.05) 7.54(0.05) 0.24(0.08, 0.39) 0.003c 0.44(0.07, 0.82) 0.020c 0.329
Cortex 7.40(0.02) 7.30(0.03) 0.10(0.02, 0.18) 0.012c 0.45(0.04, 0.86) 0.030c 0.191
WMHs 9.38(0.11) 8.93(0.19) 0.45(0.04, 0.86) 0.031c 0.50(0.11, 0.88) 0.012c 0.264
NAWM – normal appearing white matter; DGM – deep grey matter; WMHs – white matter hyperintensities; 
SE – standard error; CI – confidence interval
a Unadjusted
b Adjusted for age, sex and cardiovascular factors
c Remained significant after testing for multiple comparisons
d ΔMean refers to the differences in mean of the IVIM parameter between the cSVD and control group
e β is the regression coefficient of the independent variable group (0=control; 1=cSVD) in the multivariable 
regression model
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Table 3 and Figure 2 show the relation of the perfusion volume fraction f and the parenchymal 
diffusivity D with the WMH load in patients. Higher D in all ROIs was significantly associated 
with higher WMH load. Accounting for confounding effects of age, sex, and cardiovascular 
factors, the association weakened but remained significant. For the perfusion volume fraction 
f, a positive association with the WMH load was also present in all ROIs except in the WMHs. 
Moreover, this association remained significant (though slightly weaker) after adjusting for age, 
sex and cardiovascular factors.
Table 3. Association of perfusion volume fraction f and parenchymal diffusivity D with WMHs load in 
patients with cSVD
Model 1a 
β(95% CI)c p-value R2
 Model 2b
 β(95% CI)c p-value  R2
Perfusion volume fraction f
NAWM 1.89(0.51, 3.27) <0.01 0.095 1.49(0.21, 2.78) 0.024 0.389
DGM 1.86(1.00, 2.72) <0.001 0.207 1.14(0.23, 2.05) 0.015 0.397
Cortex 1.58(0.57, 2.59) <0.01 0.121 1.19(0.25, 2.13) 0.014 0.398
WMHs 0.13(-0.87, 1.13) 0.794 0.132 -0.02(-0.94, 0.91) 0.972 0.328
Parenchymal diffusivity D 
NAWM 311(227, 395) <0.001 0.436 253 (153, 353) <0.001 0.529
DGM 221(155, 287) <0.001 0.384 178 (103,252) <0.001 0.513
Cortex 406 (273, 539) <0.001 0.342 302(162, 443) <0.001 0.488
WMHs 105 (78,132) <0.001 0.455 97 (66, 128) <0.001 0.588
NAWM – normal appearing white matter; DGM – deep grey matter; WMHs – white matter hyperintensities; 
SE – standard error; CI – confidence interval
a Unadjusted
b Adjusted for age, sex and cardiovascular factors
c β is the regression coefficient of the IVIM parameter (f or D) in the multivariable regression model 
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Figure 2-A,B. Correlation between WMH load and perfusion volume fraction f
	
A 
B 
Scatterplots showing the unadjusted correlation between the WMH load and perfusion volume fraction f in 
the white matter (A) (NAWM: white triangles; WMH: grey circles) and in the grey matter (B) (DGM: grey 
diamonds; cortex: black crosses). The WMH load increases significantly with higher perfusion volume fraction 
f in the NAWM (A), DGM and cortex (B).
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Figure 2-C,D. Correlation between WMH load and parenchymal diffusivity D
	
  
D 
C 
Scatterplots showing the unadjusted correlation between the WMH load and parenchymal diffusivity D in 
the white matter (C) (NAWM: white triangles; WMH: grey circles) and in the grey matter (D) (DGM: grey 
diamonds; cortex: black crosses). The WMH load increases significantly with higher parenchymal diffusivity 
D in the NAWM and WMH (C), and DGM and cortex (D).
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DISCUSSION
In this study, IVIM imaging was applied in cSVD for the first time. We showed that patients 
with cSVD exhibit a larger perfusion volume fraction f and a higher parenchymal diffusivity D 
in the normal appearing brain tissue (i.e. NAWM, DGM and cortex) than controls. These IVIM 
measures were also associated with the severity of WMH on MRI. 
A higher parenchymal diffusivity for patients is in good accordance with previous studies.8, 9, 26 
This measure is comparable with the better-known mean diffusivity, though without con-
taminating effects of the microvasculature. Higher mean diffusivity was proposed to indicate 
microstructural changes in tissue involving the loss of structural barriers and the increase of 
extracellular space.7, 8 In our study, higher parenchymal diffusivity, and its association with the 
disease severity, suggest that changes in the parenchymal microstructure, which are not yet vis-
ible on conventional T2-weighted images (Figure 1), are present in areas that may be vulnerable 
for potential future damage. Previously, a correlation between increased mean diffusivity and 
clinical disease severity was found in patients with cerebral autosomal-dominant arteriopathy 
with subcortical infarcts and leukoencephalopathy (CADASIL)8 using DTI.
On the contrary, our observations in the microvasculature differ with results of previous studies 
using other MR techniques. Reduced perfusion has been reported for patients with cSVD,5, 6 
while we found a larger perfusion volume fraction f. The interpretation of the perfusion volume 
fraction f is not trivial. However, the vascular nature of f has been demonstrated previously. 
Several studies have shown a good correlation between the perfusion volume fraction f and the 
cerebral blood volume using the more standard dynamic susceptibility contrast imaging.23, 24, 27 
In addition, a phantom study reported that f correlated well with flow.28  
By definition, the perfusion volume fraction f is proportional to the ratio between the signal 
contribution from the slow diffusing water in the parenchyma and the fast diffusion arising from 
flowing water in the microvasculature mimicking a random walk. Several factors that might 
contribute to the fast diffusing component, which can lead to an increased perfusion volume 
fraction f, are discussed. 
Firstly, the seemingly most straightforward explanation is that more water molecules flow 
through the microvascular network that contributes to the fast component. This can be inter-
preted as a network with more dilated vessels. Vasodilation might be present for patients either 
as a physical compensatory mechanism or as an action of antihypertensive calcium antagonists, 
the latter are known to act on the vascular smooth muscle cells causing vasodilation.29 A trend 
of larger perfusion volume fraction f was indeed observed for those using calcium antagonists 
(Supplementary Material 2.1). After adjusting for these drugs, patients with cSVD still had a 
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larger perfusion volume fraction f than controls, which indicates that vasodilation due to med-
ication might only explain the larger f in some degree.
Secondly, water flowing in another compartment, parallel to the microvasculature that follows 
the blood flow in the random network can also contribute to the fast diffusing component. 
Enlarged PVS corresponds with this thought, which in cSVD is caused by leakage of plasma into 
the perivascular space through an impaired blood brain barrier.30, 31 Indeed, a larger perfusion 
volume fraction f is associated with higher PVS score (Supplementary Material 1.3). To further 
investigate its contribution, linear regression was adjusted for enlarged PVS. Patients still had 
a larger perfusion volume fraction f, but enlarged PVS remained a significant confounder indi-
cating that it partly explains the larger f. 
Thirdly, water molecules that change more directions can increase the signal attenuation that 
contributes to the fast component. This can be depicted as increased vessel tortuosity. Previ-
ously, increased tortuosity has been shown in cSVD using histology (e.g. the retina and cerebral 
arteries).32-35 
Briefly, previous studies have demonstrated the microvascular nature of the perfusion volume 
fraction f. Although the interpretation of the perfusion volume fraction f is complex, we have 
proposed three possible factors for an increased f. Future studies are needed to investigate this 
in more details. Furthermore, based on the observed correlation of a larger f with the severity of 
WMH in our study, it can be hypothesized that regions with a larger f might be indicative of areas 
at risk for (later) damage, which are not yet visible on conventional T2-weighted images (Figure 1).
The strength of the current study is that it was performed in a well-defined cSVD group, which 
indicates that findings can be clearly related to cSVD, and effects of confounders have been con-
trolled for. Moreover, in contrast with mean diffusivity, the IVIM-derived parenchymal diffusivity 
D is without contaminating effects of the microvasculature and therefore provides a more accurate 
measure for the parenchymal integrity. Furthermore, IVIM provides the opportunity to assess the 
perfusion and diffusion without the use of a contrast agent, which is relevant for patients with 
impaired kidney function.36, 37 In addition, an inversion recovery pre-pulse was applied to mini-
mize contamination from CSF to ensure accurate calculation of the IVIM measures. 
However, this study also has a few limitations. Firstly, the IVIM technique assumes a two-com-
partment model, which might be an oversimplification of the actual underlying structure and 
also for pathological regions (i.e. WMHs) (Supplementary Material 1.5). Secondly, we performed 
IVIM imaging in one direction. Imaging in more directions can provide more information on 
the directionality of the white matter. However, the longer scan times needed for more direc-
tions also substantially decrease patient comfort and may cause more motion artefacts. Thirdly, 
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carotid imaging was performed to ensure changes in the small vessels were not due to large 
vessel pathology. We cannot fully exclude that patients with mVCI and controls had no carotid 
stenosis, since no carotid imaging was performed for these participants. In addition, we do not 
know the precise effect of carotid stenosis on the IVIM parameters. Future studies are needed to 
examine their relation. Lastly, patients with mVCI may have coexisting pathologies in addition 
to cSVD, for example neurodegeneration (e.g. Alzheimer’s disease). To prevent contamination 
as much as possible, we tried to select only the patients that were diagnosed with mVCI most 
probably due to cSVD. This diagnosis was given after extensive evaluation of patient history, 
physical examination, neuropsychological assessment and MRI scans. Furthermore, patients 
showing evident atrophy in the hippocampi on MR images, which are one of the hallmarks of 
Alzheimer’s disease, were excluded. 
To conclude, we demonstrated the first application of IVIM in cSVD. The increased paren-
chymal diffusivity D reflects the expected microstructural impairment in cSVD. However, the 
increased perfusion volume fraction f is not fully in agreement with the reported hypoperfusion 
in cSVD. Cautious interpretation of the perfusion volume fraction f in cSVD is needed, as f 
might not be purely blood flow-related. Future studies are needed to investigate this. Neverthe-
less, IVIM imaging showed abnormalities in both the parenchymal diffusivity D and perfusion 
volume fraction f, which increased with disease severity. This indicates the potential of IVIM 
imaging to provide a surrogate marker for the progression of cSVD. 
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SUPPLEMENTARY MATERIAL
1.1 Patients with lacunar stroke
Patients with lacunar stroke were defined as patients who have a first-ever acute lacunar stroke 
syndrome with a compatible recent small subcortical infarct on brain MRI.12 A recent small 
subcortical lesion was defined as a small (<20mm) lesion in the brain stem, thalamus, basal 
ganglia, internal capsule or white matter, and hyperintense on diffusion weighted (DW) MRI 
and either normal or hyperintense on T2 and fluid-attenuated inversion recovery (FLAIR) MRI. 
If no such lesion was visible on imaging, established clinical criteria for lacunar stroke syndrome 
were used consisting of unilateral motor and/or sensory signs that involved the whole of at least 
two of the three body parts (face, arm, leg), without disturbance of consciousness, visual fields, 
language, or other cortical functions.13 
1.2 Signal-to-noise ratio
To increase the signal-to-noise ratio (SNR) of the diffusion weighted images, the images were 
smoothed with a 3 mm full-width-at-half-maximum Gaussian kernel. The SNR was deter-
mined using the NEMA method.22 A large area of the white and grey matter was chosen as ROI 
excluding areas with distortions. The SNR of our smoothed IVIM images at b = 1000 s/mm2 was 
45. Wu et al. reported that the minimal SNR for accurate estimation at b = 1000 s/mm2 should 
be at least 30.23 Our SNR at b = 1000 s/mm2 is larger than minimal required SNR for accurate 
estimation. Please appreciate the SNR as a function of b-value in Figure I. 
Figure I: The signal-to-noise ratio (SNR) as a function of the b-value 	
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1.3 Enlarged perivascular spaces
We hypothesized that enlarged perivascular spaces (PVS) might contribute to the vascular 
component in the IVIM model and hence mimic a larger perfusion volume fraction f. There-
fore, PVS score was added as a potential confounder in the analysis of vascular IVIM measures. 
Enlarged PVS were defined as round, oval, or linear-shaped lesions with a smooth margin, 
absence of mass effect and with signal intensity equal to CSF on T2-weighted images, and (if vis-
ible) hypointense on fluid attenuated inversion recovery/T1 images without a hyperintense rim. 
Lesions are <3 mm in diameter.31, 38 PVS were identified and scored by two vascular neurologists 
in the basal ganglia and the centrum semiovale on 1 slide and 1 hemisphere showing the most 
PVS. The following definitions were used: none-moderate indicates lower than 25 PVS and 
severe more than 25 PVS. The PVS score was significantly correlated with the perfusion volume 
fraction in the DGM (Pearson correlation: 0.354, p<0.001). In the multivariable linear regres-
sion model adjusting for enlarged PVS, a significant larger f was still present for the patients 
compared with controls in the centrum semiovale (NAWM: β (95% CI) = 0.54 (0.14, 0.95), 
p=0.010) and in the basal ganglia (DGM: β (95% CI) = 0.51 (0.09, 0.93), p=0.019). Moreover, 
in the DGM the enlarged PVS remained significant in the regression analysis (β (95% CI) = 
0.53 (0.03, 1.02), p=0.037). 
1.4 Adapted IVIM model
To account for contamination of CSF and also differences in relaxation time between blood and 
tissue, a modified IVIM model17 was employed in this study:
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where TI is the inversion time, TR is the repetition time, TE is the echo time, T1tis and T1bl are the 
longitudinal relaxation time of tissue and blood respectively and T2tis and T2bl are the transversal 
relaxation time of tissue and blood respectively. The following values were used: T1tis = 1081 ms, 
T2tis = 95 ms, T1bl = 1624 ms, T2bl = 275 ms and TI = 2230 ms.39-42
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1.5 Two-step curve fitting method
The two-step method24 has been conducted to fit the IVIM model to the obtained diffusion 
weighted signal. Firstly, assuming that the contribution of the intravascular component at 
high b-values can be neglected, the IVIM signal was fitted with a mono-exponential decay 
for b-values ≥ 200 s/mm2 to estimate the parenchymal diffusivity D (Figure II). Secondly, 
the intravascular diffusivity D* and the perfusion volume fraction f were estimated by fit-
ting the IVIM signal with a bi- exponential decay using all b-values and a fixed D, which 
was previously calculated (Figure II). The fit procedure is performed voxel-by-voxel using 
Matlab (MathWorks, Natick, MA) and a non-linear least squared ‘trust-region-reflective’ 
algorithm. 
To account for the goodness of fit of the diffusion-attenuated curve to the IVIM model, the sum 
of squared residuals (SSR) was calculated for each voxel and is defined as:
𝑆𝑆𝑆𝑆𝑆𝑆 =	%(𝑓𝑓( − 𝑦𝑦(),
-
(./
	 [3]
where fb is the fitted value, yb the measured value on b-value b and n is the number of b-values. A 
threshold per image was calculated based on 2.5 times the standard deviation of all SSRs of that 
particular image. Voxels exceeding this threshold were considered to have less accurate fit of the 
diffusion-attenuated curve to the IVIM model and were excluded. On average 97.9±0.8% of all 
voxels in the cerebrum were included for the participants. Moreover, the relative SSR, defined as:
𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 =	
∑ (𝑓𝑓) − 𝑦𝑦))-.)/0
∑ (𝑦𝑦))-.)/0
× 100%																																																					 [4]
was calculated to represent the more intuitive percentage fit error. This rSSR is 0.005% (NAWM), 
0.012% (DGM), 0.0075% (cortex) and 0.0067% (WMHs). These low values showed that the 
goodness of fit over all ROIs was good and that the goodness of fit in pathological tissue (e.g. 
WMHs) was in between that of normal appearing white and grey matter.
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Figure II. Two-step method
	
A two-step method was used to fit the bi-exponential decay. First a mono-exponential curve is fitted for b-values 
larger than 200s/m m2 (blue line) to estimate the parenchymal diffusivity D. Subsequently a bi-exponential 
curve was fitted for all b-values (red line) with fixed D to estimate the perfusion fraction f and intravascular 
diffusivity D*.
2.1 Exclusion 
For this study 123 participants were included. Eleven participants were excluded for the anal-
ysis; six due to MRI abnormalities fitting the aforementioned exclusion criteria, three due to 
unusable diffusion weighted images as a consequence of image artefacts, and two patients were 
excluded as a result of image processing complications. This resulted in 112 participants from 
which 73 patients with cSVD, from which 40 patients with lacunar stroke and 33 with mild 
vascular cognitive impairment, and 39 healthy controls.
2.2 Effect of medication
As calcium antagonists are known to cause vasodilation29, we investigated whether this medica-
tion is a contributing factor to the increased perfusion volume fraction f observed for patients 
with cSVD. 
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More patients with cSVD (20.0%) use calcium antagonist than controls (10.3%), but this dif-
ference was not significant (p=0.29). In a linear regression analysis adjusted for age and sex, a 
trend of larger perfusion volume fraction f was observed in the NAWM (p=0.06) and cortex 
(p<0.01) for those who use calcium antagonists. However, when adjusting for the usage of 
these drugs in a multivariable regression analysis where cardiovascular factors are taken into 
account, the perfusion volume fraction f for patients with cSVD was still significantly higher 
compared with controls (p<0.03 except in the WMHs). This indicates that cSVD intrinsically, 
thus independent of calcium antagonists intake, gives rise to an increased perfusion volume 
fraction f relative to controls.
Table I. Baseline characteristics of patients with lacunar stroke and mVCI
 LS mVCI p-value
(N=40) (N=33)
Age, y, mean(SD) 66 (12) 75 (8) <0.01
Male, N(%) 27 (68) 16 (49) 0.15
Hypertension, N(%) 27 (68) 19 (58) 0.26
Hypercholesterolemia, N(%) 33 (83) 14 (42) <0.01
Diabetes Mellitus, N(%) 4 (10) 8 (24) 0.12
Smoking, N(%) 12 (30) 6 (18) 0.29
Body mass index, mean(SD) 25 (3.9) 25 (3.9) 0.26
Educationa 0.49
   High, N(%) 9 (23) 4 (12)
   Moderate, N(%) 14 (54) 12 (46)
   Low, N(%) 17 (43) 17 (52)
Calcium antagonists intake N(%) 6 (15) 8 (24) 0.38
WMH load, mean (SD)x10-3 11 (13) 19 (16) 0.02
Presence of severe PVSb
   Centrum semiovale N(%) 17 (43) 13 (39) 0.80
   Basal ganglia N(%) 8 (20) 9 (27) 0.27
Abbreviations: LS – lacunar stroke; WMH – white matter hyperintensity; PVS – perivascular spaces
aEducation level: low: finished high school or lower; moderate: finished intermediate vocational education; 
high: finished university degree [15].
b These values represent participants with more than 25 PVS (Supplementary Material 1.3) 
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Table II. Intravascular diffusivity D* and the perfusion-related measure fD* of patients with cSVD and 
controls in different ROIs.
cSVD 
(N=73)
Controls 
(N=39)
Model 1a
ΔMean (95% CI)d p-value
Model 2b
β (95% CI)e p-value R2
Intravascular diffusivity D* x10-2 (SE) mm2/s
NAWM 1.70 (0.06) 1.63 (0.07) 0.06 (-0.12, 0.25) 0.500 0.02 (-0.42, 0.45) 0.936 0.06
DGM 2.19 (0.10) 2.02 (0.08) 0.17 (-0.09, 0.42) 0.205 0.14 (-0.29, 0.56) 0.522 0.14
Cortex 3.09 (0.13) 3.05 (0.18) 0.04 (-0.40, 0.47) 0.56 -0.07 (-0.50, 0.36) 0.756 0.10
WMH 8.00 (0.02) 7.85 (0.03) 0.02 (-0.05, 0.08) 0.661 0.05 (-0.43, 0.52) 0.844 0.07
Perfusion-related measure f∙D* x10-4 (SE) mm2/s
NAWM 4.18 (0.18) 3.87 (0.24) 0.31 (-0.30, 0.92) 0.314 0.09 (-0.35, 0.52) 0.688 0.06
DGM 8.11 (0.52) 6.81 (0.48) 1.31 (-0.09, 2.71) 0.066 0.26 (-0.15, 0.68) 0.213 0.17
Cortex 10.3 (0.61) 9.87 (0.86) 0.40 (-1.69, 2.50) 0.701 -0.04 (-0.46, 0.39) 0.869 0.11
WMH 2.57 (0.06) 2.36 (0.12) 0.12 (-0.03, 0.45) 0.082 0.36 (-0.11, 0.83) 0.127 0.08
NAWM – normal appearing white matter; DGM – deep grey matter; WMHs – white matter hyperintensities; 
SE – standard error; CI – confidence interval; R2 – R-squared of the linear regression model
a Unadjusted Student’s t-test 
b Linear regression adjusted for age, sex, and cardiovascular factors
c Remained significant after testing for multiple comparisons.
d ΔMean refers to the differences in mean of the IVIM parameter between the cSVD and control group.
e β is the regression coefficient of the independent variable group (0=control; 1= cSVD) in the multivariable 
regression model
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Table III. Perfusion volume fraction f and parenchymal diffusivity D of patients with lacunar stroke and 
mVCI
LS 
(N=40)
mVCI 
(N=33)
Model 1a
ΔMean(95% CI)d p-value
Model 2b
β(95% CI)e p-value R2
Perfusion volume fraction fx10-2 (SE) 
NAWM 2.33 (0.04) 2.31 (0.04) -0.01(-0.12, 0.10) 0.823 0.15(-0.45,0.75) 0.621 0.120
DGM 2.85 (0.05)  3.07 (0.06) 0.22 (0.06, 0.38) 0.008c 0.62 (0.07, 1.16) 0.027 0.229
Cortex 2.52 (0.05) 2.54 (0.06) 0.03 (-0.12, 0.18) 0.700 0.31 (-0.29,0.90) 0.303 0.129
WMHs 3.24 (0.06) 3.18 (0.05) 0.07 (-0.23, 0.10) 0.430 -0.27(-0.84, 0.30) 0.347 0.141
Parenchymal diffusivity Dx10-4 (SE) mm2/s
NAWM 7.27 (0.05) 7.44 (0.04) 0.17(0.03, 0.31) 0.014c 0.27 (-0.24, 0.77) 0.297 0.318
DGM 7.73 (0.06) 7.82 (0.07) 0.09 (-0.10, 0.28) 0.334 -0.03 (-0.57,0.52) 0.914 0.281
Cortex 7.37 (0.04) 7.44 (0.03) 0.07 (-0.03, 0.17) 0.148 0.12 (-0.47, 0.70) 0.691 0.193
WMHs 9.18 (0.17) 9.63 (0.12) 0.45 (0.03, 0.87) 0.034 -0.05(-0.62,-0.79) 0.858 0.344
LS – lacunar stroke; NAWM – normal appearing white matter; DGM – deep grey matter; WMHs – white matter 
hyperintensities; SE – standard error; 
CI = confidence interval; R2 = R-squared of the linear regression model
aUnadjusted Student’s t-test 
b Linear regression adjusted for age, sex, and cardiovascular factors.
c Remained significant after testing for multiple comparisons.
d ΔMean refers to the differences in mean of the IVIM parameter between the LS and mVCI group.
e β is the regression coefficient of the independent variable group (0=LS; 1= mVCI) in the multivariable regres-
sion model
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Table IV. Intravascular diffusivity D* and the perfusion-related measure fD* of patients with lacunar 
stroke and mVCI 
LS 
(N=40)
mVCI 
(N=33)
Model 1a
ΔMean(95% CI)d p-value
Model 2b
β(95% CI)e p-value R2
Intravascular diffusivity D* x10-2 (SE) mm2/s
NAWM 1.68 (0.06) 1.71 (0.10) 0.03 (-0.20, 0.26) 0.803 0.20 (-0.41,0.82) 0.511 0.068
DGM 1.97 (0.07) 2.45 (0.17) 0.48 (0.08, 0.89) 0.019c 0.53 (-0.11, 1.16) 0.105 0.197
Cortex 3.31 (0.16) 2.82 (0.20) -0.50 (-1.00,0.01) 0.055 -0.22 (-0.80, 0.36) 0.444 0.138
WMHs 0.81 (0.02) 0.79 (0.03) 0.01 (-0.08,0.06) 0.758 -0.10 (-0.61, 0.42) 0.706 0.123
Perfusion-related measure f∙D* x10-4 (SE) mm2/s 
NAWM 4.18 (0.22) 4.18 (0.31) 0.00 (-0.75,0.74) 0.996 0.12 (-0.48, 0.72) 0.684 0.070
DGM 6.77 (0.58) 9.75 (0.83) 2.98 (0.95, 5.01) 0.005c 0.67 (0.07, 1.28) <0.01 0.234
Cortex 11.2 (0.85) 9.14 (0.85) -2.06 (-4.48,0.35) 0.093 0.14 (-0.74, 0.41) 0.561 0.143
WMHs 2.63(0.09) 2.51 (0.09) 0.12 (-0.37, 0.14) 0.354 -0.38 (-0.90, 0.14) 0.147 0.127
LS – Lacunar stroke; NAWM – normal appearing white matter; DGM – deep grey matter; WMHs – white 
matter hyperintensities; SE – standard error; CI – confidence interval; R2 – R-squared of the linear regression 
model
a Unadjusted Student’s t-test
b Linear regression adjusted for age, sex, and cardiovascular factors.
c Remained significant after testing for multiple comparisons.
d ΔMean refers to the differences in mean of the IVIM parameter between the LS and mVCI group.
e β is the regression coefficient of the independent variable group (0=LS; 1= mVCI) in the multivariable regres-
sion model
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ABSTRACT
Objectives
Cerebral small vessel disease (SVD) is associated with cognitive impairment. This may be due to 
decreased microstructural integrity and microvascular perfusion but data on these relationships 
are scarce. We determined the relationship between cognition and microvascular perfusion, 
and microstructural integrity, in SVD patients, using Intravoxel Incoherent Motion imaging 
(IVIM) - a diffusion weighted MRI technique designed to determine microvascular perfusion 
and microstructural integrity simultaneously. 
Methods
Seventy-three patients with SVD and thirty-nine controls underwent IVIM imaging and neu-
ropsychological assessment. Parenchymal diffusivity D (a surrogate measure of microstructural 
integrity) and perfusion related measure fD* were calculated for the normal appearing white 
matter (NAMW), white matter hyperintensities (WMH) and cortical grey matter (CGM). The 
associations between cognitive performance and D, and fD* were determined. 
Results
In SVD patients, multivariable analysis showed that lower fD* in the NAWM and CGM was 
associated with lower overall cognition (p=0.03 and p=0.002 respectively), lower executive func-
tion (p=0.04 and p=0.01 respectively) and lower information processing speed (p=0.04 and 
p=0.01 respectively). D was not associated with cognitive function. In controls, no association 
was found between D, fD* and cognition. 
Conclusions 
In SVD patients, lower cognitive performance is associated with lower microvascular perfusion 
in the NAWM and CGM. Our results support recent findings that both CGM and NAWM 
perfusion may play a role in the pathophysiology of cognitive dysfunction in SVD.
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INTRODUCTION
Cerebral small vessel disease (SVD) causes lacunar stroke syndrome and is an important con-
tributor to cognitive impairment and dementia. Radiological markers of SVD such as white 
matter hyperintensities (WMH) and lacunes, are found mainly in the subcortical white matter, 
and have been associated with impaired cognitive function.1, 2 Recent papers suggest that cor-
tical changes such as a lower cortical thickness and lower total cortical volume may also play 
a role in SVD.3 
The exact pathophysiology of cognitive deterioration in SVD remains unclear. It has been pro-
posed that microstructural damage and reduced cerebral perfusion may play an integral part 
in this process. Diffusion tensor imaging studies found diminished microstructural integrity 
and network efficiency of the white matter in SVD patients compared with controls.4 Moreo-
ver, lower microstructural integrity in the white matter was found to be associated with lower 
cognitive function.5, 6 In addition to microstructural changes, multiple studies showed reduced 
cerebral perfusion in patients with SVD.7-9 Most of these studies examined perfusion differences 
between patients with cognitive impairment and a control group, whereas studies on the direct 
relationship between cognition and perfusion in patients with SVD are scarce.
Intravoxel Incoherent Motion (IVIM) imaging is a diffusion weighted MRI technique designed 
to determine microvascular perfusion and microstructural integrity simultaneously. IVIM gen-
erates a number of measures concurrently, including D (parenchymal diffusivity) and fD*. A 
higher D indicates less restricted water diffusion, which is surrogate for a decreased microstruc-
tural integrity. A higher fD* is surrogate for a higher microvascular perfusion.10-12 Earlier studies 
using dynamic susceptibility-contrast MRI and arterial spin labelling MRI in patients with 
gliomas found that perfusion related parameters in IVIM correlated with cerebral blood volume 
and cerebral blood flow.13-15 The IVIM technique enables concurrent analysis of microstructural 
integrity and microvascular perfusion and the possibly combined contribution to cognition. 
We used IVIM to examine microvascular perfusion and microstructural integrity in the white 
matter and cortical grey matter (CGM), and their association with cognition in patients with 
SVD, and in controls. To have a broad clinical spectrum linked to SVD, we included patients 
with lacunar stroke and patients with SVD related vascular cognitive impairment.1
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METHODS
Patient population
We included clinically overt SVD patients and age- and sex-matched controls. Patients with 
SVD consisted of consecutively included first-ever lacunar stroke patients and patients with 
mild vascular cognitive impairment (mVCI) who consented to participate in the study. Partic-
ipants were included from the Maastricht University Medical Centre and Zuyderland Medical 
Centre, The Netherlands, between April 2013 and December 2014. Lacunar stroke patients 
were recruited from the Stroke Unit. Lacunar stroke was defined as an acute stroke syndrome 
with a compatible recent small subcortical infarct on clinical brain MRI. This was determined 
as a round or ovoid hyperintense lesion on a DWI sequence and/or a hyperintense lesion on 
both FLAIR and T2-weighted sequences, all with a diameter of <20mm in the axial plane.16 If 
no such lesion was visible on MRI or only CT was performed, established clinical criteria for 
lacunar stroke syndrome were used.17 Exclusion criteria included a potential cardiac embolic 
source (e.g. atrial fibrillation), symptomatic carotid stenosis of ≥50%, or recent cortical infarct 
on brain MRI or CT. Stroke patients were included at least three months post-stroke to avoid 
acute stroke changes.18 mVCI patients were recruited from the outpatient clinic of the Depart-
ment of Neurology and from the Memory Clinic. Criteria of mVCI were met when patients had 
1) subjective complaints of cognitive functioning, and 2) objective cognitive impairment in at 
least one cognitive domain at neuropsychological testing, and 3) a Clinical Dementia Rating 
of ≤1 and a Mini Mental State Examination score of ≥20, and 4) vascular lesions on brain MRI 
that suggest a link between the cognitive deficit and SVD19: moderate to severe white matter 
hyperintensities (WHM; Fazekas score deep>1 and/or periventricular>2), or mild WMH (Faze-
kas score deep=1 and/or periventricular=2) combined with lacune(s) and/or microbleeds.20 
Age- and sex-matched controls were recruited from the outpatient clinic of the Department of 
Neurology. We included one control per two SVD patients. Controls had no overt cerebrovas-
cular diseases and/or cognitive impairment. Most of them had lumbar radicular syndrome or 
peripheral neuropathy. Additional exclusion criteria for all participants include neurodegen-
erative diseases, multiple sclerosis, epilepsy, systemic inflammatory diseases, alcohol abuse, 
psychiatric disorders or use of medication that may influence the accuracy of neuropsychologi-
cal testing, and the presence of a contra-indication for MRI (e.g. pacemaker and claustrophobia). 
Characteristics of all participants were recorded including age, sex, educational level and the 
presence of cardiovascular risk factors including hypertension (history of hypertension and/or 
use of blood pressure lowering drugs), hypercholesterolemia (history of hypercholesterolemia 
and/or use of statin), diabetes mellitus (history of diabetes mellitus or use of blood sugar low-
ering drugs), smoking (current smoking) and Body Mass Index (BMI: weight divided by the 
square of length).
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The Medical Ethical Committee of the Maastricht University Medical Centre approved the 
study. All participants were included after written informed consent. The study is registered on 
www.trialregister.nl (NTR number NTR3786). 
Magnetic Resonance Imaging 
All participants underwent standard brain imaging on a 3.0 Tesla MRI system. The MR proto-
col consisted of a T1 weighted, T2 weighted and fluid-attenuated inversion recovery (FLAIR) 
sequence. 
After this standard protocol, IVIM imaging was performed using a Stejskal-Tanner diffu-
sion weighted single-shot echo-planar-imaging spin echo pulse sequence.21 Fifteen diffusion 
weighted images were acquired in the anterior-posterior direction using multiple diffusion 
sensitive b-values. More sequence and image processing details can be found in the Supple-
mentary Material.
Image Processing
Using Freesurfer software, white matter and CGM were segmented on T1 weighted scans.22 
WMH were automatically segmented, with manual correction, on FLAIR scans to differentiate 
between normal appearing white matter (NAWM) and WMH.23 WMH volume was quantified 
and normalized to the intracranial volume. Parenchymal brain volume, normalized to total 
intracranial volume was used as a measure for atrophy.24 
A two-compartment diffusion model was used to quantitatively model the diffusion attenuated 
signal.12 This model describes an intravascular and parenchymal (non-vascular) compartment. 
The intravascular compartment represents the fast water motion in blood flowing into a network 
of small vessels. This compartment provides a perfusion related measure, fD*, in which D* is 
the pseudo-diffusivity of water in the flowing blood and f is the fractional volume of blood. The 
extravascular compartment is described by the water diffusion in the parenchymal microstruc-
ture and gives rise to the parenchymal diffusivity D. 
To account for the pre-pulse to suppress CSF and also differences in relaxation time of blood 
and tissue, we employed the modified IVIM model proposed by Hales and Clark.24 
To calculate D and fD*, model fitting was performed voxel-by-voxel using the two-step method 
introduced by Federau et al.13 Subsequently, values were obtained of D and fD* for the NAWM, 
WMH and CGM. In this study we focus on D and fD* as a surrogate measure for parenchymal 
microstructural integrity and microvascular perfusion, respectively. 
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Neuropsychological assessment
All participants received extensive neuropsychological testing covering three main cognitive 
domains. The memory domain was measured with the Rey Auditory Verbal Learning Test 
(immediate recall, delayed recall, delayed recognition) and the Digit Span Forward. Executive 
function domain was tested using the Stroop Colour-Word Test interference score (time of 
part 3 minus mean time of part 1 and 2), Trail Making Test interference score (time of part B 
minus time of part A), Category (animals and professions) and Letter Fluency, Letter-Number 
Sequencing and Digit Span Backward. Information processing speed was determined using the 
Symbol Substitution-Coding, Trail Making Test part A and Stroop Colour-Word Test parts 1 
and 2. The z-scores were calculated for each test by dividing the difference between the indi-
vidual raw score and the sample mean by the sample standard deviation. Compound scores 
were determined for each participant by averaging the z-scores within each domain. An overall 
cognition compound score was calculated taking the average of the three domain compound 
scores. When not all tasks could be performed, compound scores were calculated from the 
scores of the remaining tasks. We used the Hamilton Anxiety and Depression Scale test (range 
0-42) to record depression and anxiety symptoms. 
Statistical analysis
To examine the relationship between the compound scores of the different cognitive domains 
(dependent variables), and D and fD* (independent variables) in the NAWM, WMH and CGM, 
we used univariable and multivariable linear regression, corrected for age, sex, educational level, 
Hamilton Anxiety and Depression Score. Significant associations were further corrected for 
normalized WMH volume and normalized brain volume (markers for macrostructural brain 
damage). These analyses were carried out for SVD patients and controls, and also for the SVD 
subgroups lacunar stroke and mVCI separately. A possible interaction effect of D and fD* on 
cognition in SVD patients was tested by adding an interaction term in the multivariable linear 
regression analysis. Statistical analysis was performed using SPSS 22.0. Statistical significance 
was inferred for p<0.05.
RESULTS
We included 73 patients with SVD – 40 patients with lacunar stroke and 33 patients with mVCI 
– and 39 age- and sex-matched controls. We initially included 80 patients and 40 controls but 
due to imaging complications and image artefacts, we had to exclude seven patients and one 
control for the final analysis. Of the 40 lacunar stroke patients, 31 had a recent lesion visible on 
MRI and 9 (5 with MRI and 4 with CT) were included based on clinical presentation. Charac-
teristics of these participants are presented in Table 1. 
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For cognitive scores on all individual tests, see Supplementary Material. In six SVD patients, one 
or two neuropsychological tasks were not performed due to mild motor deficit or insufficient 
comprehension of the task instructions. 
In patients with SVD, univariable analysis showed that higher D in NAWM, WMH and CGM 
was significantly associated with lower scores on overall cognition, executive function, infor-
mation procession speed and memory, except for cortical D and memory and speed (Table 2). 
After correcting for age, sex, educational level, Hamilton Anxiety and Depression Score, D was 
no longer associated with any cognition measure (Table 3). Age and educational level appeared 
to be important confounders as they largely explained the observed associations between D and 
cognition in the univariable analysis. 
Microstructural integrity (parenchymal diffusivity D)
In a separate multivariable analysis for each subgroup (lacunar stroke and mVCI), D was not 
associated with cognitive function (Supplementary Material). 
In controls, univariable analysis showed that higher D in the NAWM and CGM was associated 
with lower scores on executive function (β -0.436, p=0.01 for NAWM; β -0.338, p=0.04 for 
CGM). After correcting for age, sex, education level, Hamilton Anxiety and Depression Score, 
these associations were no longer significant (Supplementary Material).
Table 1. Characteristics of SVD patients and control
SVD patients
N=73
Controls
N=39
Age, years (SD) 70 (11) 69 (12)
Male (%) 43 (59) 23 (59)
Educational level
   Low 34 (47) 13 (33)
   Average 26 (36) 20 (51)
   High 13 (18) 6 (15)
WMH volume (SD)* 0.014 (0.014) 0.005 (0.010)
Brain volume (SD)* 0.670 (0.050) 0.693 (0.039)
Hypertension (%) 46 (63) 18 (46)
Hypercholesterolemia (%)* 47 (64) 13 (33)
Diabetes (%) 12 (16) 4 (10)
BMI kg/m2 (SD) 25 (4) 27 (3)
Smoking (%)* 18 (24) 3 (8)
WMH volume – WHM volume normalized to intracranial volume; Brain volume – brain volume normalized 
to intracranial volume; BMI – body mass index
*p<0.05 SVD patients compared with controls
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Table 2. Association between cognition and D and fD* in SVD patients, uncorrected 
Overall Executive Speed Memory
D β p-value β p-value β p-value β p-value
NAWM -0.376 0.001* -0.380 0.001* -0.285 0.02* -0.309 0.01*
WMH -0.356 0.002* -0.406 <0.001* -0.239 0.04* -0.280 0.02*
CGM -0.245 0.04* -0.251 0.03* -0.229 0.05 -0.161 0.17
fD* β p-value β p-value β p-value β p-value
NAWM 0.142 0.23 0.121 0.31 0.141 0.23 0.106 0.37
WMH -0.136 0.25 -0.177 0.14 -0.175 0.14 -0.018 0.88
CGM 0.311 0.01* 0.271 0.02* 0.281 0.02* 0.251 0.03*
β values represent standardized regression coefficients. NAWM – normal appearing white matter; WMH – 
white matter hyperintensities; CGM – cortical grey matter
Table 3. Association between cognition and D and fD*, in SVD patients, corrected for age, sex, educational 
level, Hamilton Anxiety and Depression Score
Overall Executive Speed Memory
D β p-value β p-value β p-value β p-value
NAWM -0.093 0.41 -0.130 0.27 -0.003 0.98 -0.108 0.39
WMH -0.081 0.48 -0.191 0.10 0.005 0.97 -0.036 0.78
CGM -0.021 0.84 -0.054 0.63 -0.009 0.94 -0.027 0.98
fD* β p-value β p-value β p-value β p-value
NAWM 0.202 0.03* 0.197 0.04* 0.220 0.04* 0.115 0.28
WMH -0.142 0.16 -0.160 0.12 -0.164 0.15 -0.055 0.62
CGM 0.289 0.002* 0.271 0.01* 0.304 0.01* 0.183 0.09
β values represent standardized regression coefficients. NAWM – normal appearing white matter; WMH – 
white matter hyperintensities; CGM – cortical grey matter
Microvascular perfusion (fD*)
In patients with SVD, lower fD* in the CGM was significantly associated with lower perfor-
mance in all cognitive domains in univariable analysis (Table 2). After correcting for age, sex, 
educational level, Hamilton Anxiety and Depression Score, fD* in the NAWM and CGM was 
significantly associated with overall cognition, executive function and information processing 
speed (Table 3). After additional correction for WMH volume and brain volume, the associa-
tions remained significant between fD* in the CGM and overall cognition, executive function 
and information processing speed (β 0.246, p=0.009; β 0.247, p=0.01; β 0.234, p=0.02, respec-
tively). 
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In lacunar stroke patients, similar associations between fD* and cognitive function were found 
in multivariable analysis, whereas no significant association were found in mVCI patients (Sup-
plementary Material).
In controls, univariable and multivariable analyses showed no association between fD* and 
cognition (Supplementary Material).
There was no interaction effect between D and fD* in the NAWM, WMH or CGM on the asso-
ciation with cognitive function, in patients with SVD (data not shown).
DISCUSSION
We examined the parenchymal microstructural integrity and microvascular perfusion con-
currently in relation to cognitive function in SVD patients and age- and sex-matched controls, 
using IVIM imaging. We found that in SVD patients, lower microvascular perfusion in the 
NAWM and CGM was independently associated with lower overall cognitive function, execu-
tive function and information processing speed. This association was not observed in controls. 
Microstructural integrity was not associated with cognition. 
The observed association between decreased microvacular perfusion in the NAWM and lower 
cognitive function supports earlier findings that NAWM in SVD may be affected before mor-
phological abnormalities (i.e. WMH) become evident, and that NAWM changes may relate to 
clinical decline.8, 25 In our study, the association between microvascular perfusion in the NAWM 
and cognitive function was no longer significant after correcting for WMH volume and brain 
volume. Apparently, WMH volume and particularly brain volume are strong confounders, and 
increases in WMH volume and decreases in brain volume possibly occur concurrently with 
changes in microvascular perfusion.
The strong association between cortical perfusion and cognition in SVD patients in our study, 
independent of WMH volume and brain volume, supports the currently evolving view that 
SVD is not a disorder solely restricted to the white matter. Increasing evidence suggests that 
cortical changes are integral in the disease process of SVD.1, 26 Cortical thinning and cortical 
microinfarcts have recently been described in SVD and in relation to cognitive function.27-31 
A reduction of capillaries and venous density in the CGM have also been reported in SVD 
patients.32, 33 It is presumable that whilst MRI abnormalities in the white matter are markers for 
SVD and associated with cognitive functioning, cortical thinning and cortical hypoperfusion 
are the main mediators for cognitive decrements in SVD patients. Whether reduced cortical 
perfusion is cause or consequence of cortical changes in SVD cannot be deduced from our study. 
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Our finding that microvascular perfusion did not relate to cognition in age-matched controls 
may suggest that the association in SVD is not merely related to ageing. However, it may also 
be due to the small variance of cognitive scores in our cognitive healthy controls.
In subgroup analysis, the association between microvascular perfusion and cognition was sig-
nificant in lacunar stroke patients but not in mVCI patients. We presume that the underlying 
pathophysiology in both groups is SVD. However, differences may exist. The lacunar stroke 
group may be a more homogenous SVD group compared with the mVCI group as some of the 
mVCI patients may have coexisting pathologies such as amyloid angiopathy or Alzheimer’s 
pathology which also can affect cognitive function.34 
We found no association between microstructural integrity and cognitive function in SVD 
patients. Age and educational level had a strong confounding effect. Recently, a study using 
IVIM examined the microstructural integrity in patients with WMH and similarly, no signifi-
cant association was found between microstructural integrity and cognitive function.35 However, 
our finding is partly dissimilar to earlier diffusion tensor imaging studies showing an association 
between cognitive function and microstructural integrity in the WMH as well as in the NAWM.4, 6 
The difference is that the patients of these aforementioned studies were selected on extensive 
WMH on brain imaging whilst ours was primarily based on clinical symptoms of SVD (i.e. 
including lacunar stroke patients without any WMH). Therefore, it is possible that the group 
composition differs with regard to the stage of the disease process. Moreover, microstructural 
integrity (in terms of D) measured by IVIM is not confounded by the vascular components 
whereas the diffusivity measure acquired by diffusion tensor imaging is contaminated by blood 
space contribution. Another methodological difference is that earlier DTI studies used multidi-
rectional protocols whereas our protocol was unidirectional. Some structures including white 
matter tracts are directionally oriented and a unidirectional protocol might be less sensitive to 
provide D values that relate to cognition. However, an earlier IVIM study using a unidirectional 
protocol found an association between higher D and lower cognitive scores in patients with 
diabetes mellitus.21 Thus, although theoretically, a protocol utilizing multiple diffusion-sensi-
tizing directions may provide more information, a unidirectional protocol should also be able 
to detect an association between D and cognition. Another study found an association between 
microstructural integrity in the NAWM and executive function in patients with lacunar stroke 
and extensive WMH.25 However, they did not correct for educational level, which is an impor-
tant determinant for cognitive function. 
There was no interaction between microstructural integrity and microvascular perfusion on 
cognition. This suggests that in patients with SVD, the association between cognition and micro-
vascular perfusion is independent of the microstructural integrity. 
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Our study has several strengths. We used clearly defined in- and exclusion criteria for SVD 
patients. This enabled us to have a well-represented spectrum of clinically overt SVD patients. By 
using IVIM, we could examine microvascular perfusion and microstructural integrity simulta-
neously in their relation with cognitive performance. In addition, IVIM has less contamination 
from large vessel signals, and is therefore more targeted at microvascular perfusion compared 
with other MR perfusion sequences including Dynamic Susceptibility Contrast MRI, making 
it a useful technique in studying SVD.11, 36 Furthermore, in contrast to many other perfusion 
methods, IVIM does not use exogenous contrast agents to measure perfusion and it is therefore 
safe and patient friendly. Apart from the technical advantages, we performed extensive neu-
ropsychological assessment, enabling us to examine a spectrum of cognitive domains. Moreover, 
in contrast to many earlier studies, we not only examined the white matter but also the CGM. 
This study was limited by a single (diffusion sensitization) axis IVIM protocol, as commented 
above. This may have led to less accurate IVIM values for the white matter. For the CGM, which 
is more isotropic at the imaging resolution scale, the use of a single axis diffusion-sensitisation 
is not expected to have any influence. Further, we did not perform carotid imaging in the 
non-stroke and control group. IVIM focuses on local microcirculation, but we cannot exclude 
an effect of arterial stenosis on the IVIM measures. Finally, as our study has a cross-sectional 
design, it is not possible to determine whether the relation between microvascular perfusion 
and cognition is of causative nature. 
In conclusion, we have demonstrated that lower microvascular perfusion, but not microstruc-
tural integrity, in the NAWM and CGM is related to lower cognitive performance in SVD. Our 
results confirm the involvement of NAWM, and emphasize the importance of cortical involve-
ment in cognitive changes in SVD. Future, longitudinal studies with IVIM should determine 
whether microvascular perfusion might be apparent before microstructural changes occur and 
can be used as a marker for disease progression in SVD. 
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SUPPLEMENTARY MATERIAL
Magnetic Resonance Imaging 
All participants underwent standard brain imaging on a 3.0 Tesla MRI system (Achieva TX, 
Philips Healthcare, Best, The Netherlands). The MR protocol consisted of a T1 weighted, T2 
weighted and fluid-attenuated inversion recovery (FLAIR) sequence. 
After this standard protocol, IVIM imaging was performed using a Stejskal-Tanner diffusion 
weighted single-shot echo-planar-imaging spin echo pulse sequence (TR/TE = 6800/84 ms; 
FOV 221x269 mm2; acquisition matrix 110x112; 58 slices; 2.0x2.4x2.4 mm cubic voxel size; 
acquisition time 5:13 minutes).21 To minimize the signal contamination of cerebral spinal fluid 
(CSF), an inversion recovery pulse (TI = 2230 ms) was given prior to the diffusion sensitization.24 
Fifteen diffusion weighted images were acquired in the anterior-posterior direction using mul-
tiple diffusion sensitive b-values (0, 5, 7, 10, 15, 20, 30, 40, 50, 60, 100, 200, 400, 700, and 1000 
s/mm2). To increase the signal-to-noise ratio the numbers of signal averages for the highest two 
b-values were two and three respectively, whereas for all other b-values this was one. 
Image Processing
Using Freesurfer software, white matter and CGM were segmented on T1 weighted scans.22 
WMH were automatically segmented, with manual correction, on FLAIR scans to differentiate 
between normal appearing white matter (NAWM) and WMH.23 WMH volume was quantified 
and normalized to the intracranial volume. Parenchymal brain volume, normalized to total 
intracranial volume was used as a measure for atrophy. 
IVIM images were corrected for image distortion and subject motion.37 Subsequently, the images 
were realigned with the T1-weighted image (FSL version 5.0) and smoothed with a 3-mm full-
width-at-half-maximum Gaussian kernel (Statistical Parametric Mapping software application, 
Wellcome Department of Cognitive Neurology, UK).38
A two-compartment diffusion model was used to quantitatively model the diffusion attenuated 
signal.12 This model describes an intravascular and parenchymal (non-vascular) compartment. 
The intravascular compartment represents the fast water motion in blood flowing into a network 
of small vessels. This compartment provides a perfusion related measure, fD*, in which D* is 
the pseudo-diffusivity of water in the flowing blood and f is the fractional volume of blood. The 
extravascular compartment is described by the water diffusion in the parenchymal microstruc-
ture and gives rise to the parenchymal diffusivity D. 
To account for the pre-pulse to suppress CSF and also differences in relaxation time of blood 
and tissue, we employed the modified IVIM model proposed by Hales and Clark.24 
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To calculate D and fD*, model fitting was performed voxel-by-voxel using the two-step method 
introduced by Federau et al.13 Subsequently, values were obtained of D and fD* for the NAWM, 
WMH and CGM. In this study we focus on D and fD* as a surrogate measure for parenchymal 
microstructural integrity and microvascular perfusion, respectively.
Table I. Neuropsychological test scores in SVD patients and controls
SVD
Mean Score (SD)
Controls
Mean Score (SD)
Rey Auditory Verbal Learning Test
   Inmediate recall* 32.1 (10.3) 36.1 (7.7)
   Delayed recall* 5.4 (3.5) 6.6 (2.5)
   Delayed recognition* 11.4 (3.2) 12.6 (2.0)
Stroop Colour-Word Test Part 1#* 57.8 (14.8) 50.1 (10.0)
Stroop Colour-Word Test Part 2#* 76.3 (20.1) 65.7 (13.5)
Stroop Colour-Word Test Part 3#* 153.9 (60.1) 119.5 (48.8)
Trail Making Test A#* 66.1 (34.5) 44.2 (15.3)
Trail Making Test B#* 179.2 (117.2) 106.4 (48.4)
Category Fluency* 30.3 (10.6) 39.0 (12.3)
Letter Fluency 24.8 (12.6) 28.7(10.5)
Symbol Substitution - Coding* 42.5 (18.7) 53.5 (18.3)
Digit Span Forward 7.4 (2.0) 7.8 (1.6)
Digit Span Backward 5.2 (1.8) 5.9 (1.5)
Letter Number Sequencing 6.7 (3.3) 7.6 (2.9)
# Test score unit is in seconds
*p<0.05 when comparing SVD and Controls
Table II. Association between cognition and D and fD*, in lacunar stroke patients, corrected for age, sex, 
educational level, Hamilton Anxiety and Depression Score
Overall Executive Speed Memory
D β p-value β p-value β p-value β p-value
NAWM -0.186 0.24 -0.183 0.29 -0.189 0.24 -0.121 0.48
WMH -0.163 0.35 -0.302 0.11 -0.025 0.89 -0.106 0.57
CGM -0.079 0.60 -0.111 0.50 -0.117 0.45 0.007 0.97
fD* β p-value β p-value β p-value β p-value
NAWM 0.322 0.02* 0.310 0.04* 0.277 0.04* 0.261 0.08
WMH -0.217 0.13 -0.231 0.14 -0.266 0.07 -0.091 0.56
CGM 0.370 0.01* 0.371 0.01* 0.320 0.02* 0.284 0.06
β values represent standardized regression coefficients. NAWM – normal appearing white matter; WMH – 
white matter hyperintensities; CGM – cortical grey matter
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Table III. Association between cognition and D and fD*, in mVCI patients, corrected for age, sex, educa-
tional level, Hamilton Anxiety and Depression Score
Overall Executive Speed Memory
D β p-value β p-value β p-value β p-value
NAWM 0.122 0.55 0.019 0.91 0.334 0.13 -0.085 0.69
WMH 0.160 0.41 -0.022 0.90 0.244 0.25 0.097 0.63
CGM 0.050 0.81 0.029 0.87 0.151 0.51 -0.063 0.77
fD* β p-value β p-value β p-value β p-value
NAWM 0.180 0.33 0.185 0.24 0.255 0.21 -0.023 0.90
WMH -0.289 0.14 -0.307 0.07 -0.207 0.35 -0.139 0.51
CGM 0.160 0.42 0.125 0.46 0.317 0.14 -0.073 0.724
β values represent standardized regression coefficients. NAWM – normal appearing white matter; WMH – 
white matter hyperintensities; CGM – cortical grey matter
Table IV. Association between cognition and D and fD*, in controls, corrected for age, sex, educational 
level, Hamilton Anxiety and Depression Score
Overall Executive Speed Memory
D β p-value β p-value β p-value β p-value
NAWM 0.028 0.85 -0.212 0.18 0.079 0.67 0.193 0.16
WMH 0.010 0.94 -0.033 0.83 0.056 0.75 -0.006 0.96
CGM -0.061 0.64 -0.204 0.16 -0.110 0.53 0.183 0.15
fD* β p-value β p-value β p-value β p-value
NAWM -0.087 0.50 -0.078 0.59 -0.167 0.33 0.056 0.66
WMH 0.035 0.80 0.212 0.17 -0.171 0.35 0.055 0.69
CGM -0.105 0.414 -0.158 0.28 -0.137 0.43 0.060 0.64
β values represent standardized regression coefficients. NAWM – normal appearing white matter; WMH – 
white matter hyperintensities; CGM – cortical grey matter
MICROSTRUCTURAL INTEGRITY, MICROVASCULAR PERFUSION AND COGNITION
 93
5
REFERENCES
1. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic chal-
lenges. Lancet Neurol. 2010;9:689-701
2. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, et al. Cerebral small-vessel disease 
and decline in information processing speed, executive function and memory. Brain. 2005;128:2034-2041
3. Peres R, De Guio F, Chabriat H, Jouvent E. Alterations of the cerebral cortex in sporadic small vessel disease: 
A systematic review of in vivo mri data. J Cereb Blood Flow Metab. 2016;36:681-695
4. Lawrence AJ, Chung AW, Morris RG, Markus HS, Barrick TR. Structural network efficiency is associated 
with cognitive impairment in small-vessel disease. Neurology. 2014;83:304-311
5. Tuladhar AM, van Norden AG, de Laat KF, Zwiers MP, van Dijk EJ, Norris DG, et al. White matter integrity 
in small vessel disease is related to cognition. Neuroimage Clin. 2015;7:518-524
6. van Norden AG, de Laat KF, van Dijk EJ, van Uden IW, van Oudheusden LJ, Gons RA, et al. Diffusion 
tensor imaging and cognition in cerebral small vessel disease: The run dmc study. Biochim Biophys Acta. 
2012;1822:401-407
7. Yao H, Sadoshima S, Kuwabara Y, Ichiya Y, Fujishima M. Cerebral blood flow and oxygen metabolism in 
patients with vascular dementia of the binswanger type. Stroke. 1990;21:1694-1699
8. O’Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, et al. Patterns of cerebral blood 
flow reduction in patients with ischemic leukoaraiosis. Neurology. 2002;59:321-326
9. Bastos-Leite AJ, Kuijer JP, Rombouts SA, Sanz-Arigita E, van Straaten EC, Gouw AA, et al. Cerebral blood 
flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am 
J Neuroradiol. 2008;29:1296-1301
10. Federau C, Maeder P, O’Brien K, Browaeys P, Meuli R, Hagmann P. Quantitative measurement of brain 
perfusion with intravoxel incoherent motion mr imaging. Radiology. 2012;265:874-881
11. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. Mr imaging of intravoxel inco-
herent motions: Application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401-407
12. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and 
perfusion in intravoxel incoherent motion mr imaging. Radiology. 1988;168:497-505
13. Federau C, O’Brien K, Meuli R, Hagmann P, Maeder P. Measuring brain perfusion with intravoxel incoherent 
motion (ivim): Initial clinical experience. J Magn Reson Imaging. 2014;39:624-632
14. Shen N, Zhao L, Jiang J, Jiang R, Su C, Zhang S, et al. Intravoxel incoherent motion diffusion-weighted 
imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin 
labeling for evaluation of tumor perfusion. J Magn Reson Imaging. 2016;44:620-632
15. Wirestam R, Borg M, Brockstedt S, Lindgren A, Holtas S, Stahlberg F. Perfusion-related parameters in 
intravoxel incoherent motion mr imaging compared with cbv and cbf measured by dynamic susceptibili-
ty-contrast mr technique. Acta Radiol. 2001;42:123-128
16. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for 
research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 
2013;12:822-838
17. Bamford J, Sandercock P, Jones L, Warlow C. The natural history of lacunar infarction: The oxfordshire 
community stroke project. Stroke. 1987;18:545-551
18. Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 
2011;42:3323-3328
19. Gorelick PB, Pantoni L. Advances in vascular cognitive impairment. Stroke. 2013;44:307-308
CHAPTER 5
94
20. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. Mr signal abnormalities at 1.5 t in alzheimer’s 
dementia and normal aging. AJR Am J Roentgenol. 1987;149:351-356
21. van Bussel FC, Backes WH, Hofman PA, van Oostenbrugge RJ, Kessels AG, van Boxtel MP, et al. On the 
interplay of microvasculature, parenchyma, and memory in type 2 diabetes. Diabetes Care. 2015;38:876-882
22. Fischl B. Freesurfer. Neuroimage. 2012;62:774-781
23. de Boer R, Vrooman HA, van der Lijn F, Vernooij MW, Ikram MA, van der Lugt A, et al. White matter lesion 
extension to automatic brain tissue segmentation on mri. Neuroimage. 2009;45:1151-1161
24. Hales PW, Clark CA. Combined arterial spin labeling and diffusion-weighted imaging for noninvasive 
estimation of capillary volume fraction and permeability-surface product in the human brain. J Cereb Blood 
Flow Metab. 2013;33:67-75
25. O’Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, Markus HS. Diffusion tensor mri cor-
relates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry. 
2004;75:441-447
26. Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A, et al. White matter lesion progression: 
A surrogate endpoint for trials in cerebral small-vessel disease. Neurology. 2004;63:139-144
27. Tuladhar AM, Reid AT, Shumskaya E, de Laat KF, van Norden AG, van Dijk EJ, et al. Relationship between 
white matter hyperintensities, cortical thickness, and cognition. Stroke. 2015;46:425-432
28. Righart R, Duering M, Gonik M, Jouvent E, Reyes S, Herve D, et al. Impact of regional cortical and subcor-
tical changes on processing speed in cerebral small vessel disease. Neuroimage Clin. 2013;2:854-861
29. De Guio F, Reyes S, Vignaud A, Duering M, Ropele S, Duchesnay E, et al. In vivo high-resolution 7 tesla 
mri shows early and diffuse cortical alterations in cadasil. PLoS One. 2014;9:e106311
30. Jouvent E, Poupon C, Gray F, Paquet C, Mangin JF, Le Bihan D, et al. Intracortical infarcts in small vessel 
disease: A combined 7-t postmortem mri and neuropathological case study in cerebral autosomal-dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 2011;42:e27-30
31. Jouvent E, Mangin JF, Duchesnay E, Porcher R, During M, Mewald Y, et al. Longitudinal changes of cortical 
morphology in cadasil. Neurobiol Aging. 2012;33:1002 e1029-1036
32. De Guio F, Vignaud A, Ropele S, Duering M, Duchesnay E, Chabriat H, et al. Loss of venous integrity in 
cerebral small vessel disease: A 7-t mri study in cerebral autosomal-dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy (cadasil). Stroke. 2014;45:2124-2126
33. Brown WR, Moody DM, Thore CR, Challa VR, Anstrom JA. Vascular dementia in leukoaraiosis may be a 
consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as 
well. J Neurol Sci. 2007;257:62-66
34. Gurol ME. Molecular neuroimaging in vascular cognitive impairment. Stroke. 2016;47:1146-1152
35. Sun J, Yu X, Jiaerken Y, Song R, Huang P, Wang C, et al. The relationship between microvasculature in white 
matter hyperintensities and cognitive function. Brain Imaging Behav. 2016;E-pub ahead of print
36. Le Bihan D, Turner R. The capillary network: A link between ivim and classical perfusion. Magn Reson Med. 
1992;27:171-178
37. Leemans A, Jeurissen B, Sijbers J, Jones D. Explore dti: A graphical toolbox for processing, analyzing, and 
visualizing diffusion mr data. Proc. 17th Sci. Meet. Int. Soc. Magn. Reson. Med. 2009;17:3537
38. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear 
registration and motion correction of brain images. Neuroimage. 2002;17:825-841


CHAPTER 6
UNCOUPLING OF MICROVASCULAR BLOOD 
FLOW AND CAPILLARY DENSITY IN VASCULAR 
COGNITIVE IMPAIRMENT
Zhang CE, Staals J, van Oostenbrugge RJ, Vink H
Manuscript submitted for publication
EM
BA
RG
OE
D
This chapter is embargoed at request
CHAPTER 7
GENERAL DISCUSSION 

GENERAL DISCUSSION
 111
7
GENERAL DISCUSSION 
Cerebral small vessel disease (cSVD) is an umbrella term that covers all pathologies of the small 
vessels of the brain. The most common subtype is an age and cardiovascular risk factors related 
disease of the small vessels (arteriolosclerosis). This thesis focuses on this common subtype of 
cSVD, hereafter shortly referred to as cSVD. cSVD is associated with debilitating disorders includ-
ing lacunar stroke and vascular cognitive impairment.1 The pathophysiological mechanisms of 
cSVD are still elusive, partly because cSVD is a chronic disease and post mortem human studies 
only provide information of the final disease stages. Therefore, imaging studies are essential to 
gain further insights in the pathophysiology of cSVD in vivo in human. Ideally, these imaging 
techniques should not only show the consequences of the disease in terms of brain damage, but 
should also be sensitive to study the different pathophysiological mechanisms involved in cSVD. 
In this thesis, we aimed to develop and apply new imaging techniques to increase our under-
standing of the pathophysiology of cSVD. We applied dynamic contrast-enhanced (DCE)-MRI, 
intravoxel incoherent motion (IVIM) MRI and sublingual intravital microscopy and examined 
different aspects of cSVD including blood-brain barrier (BBB) permeability, microstructural 
integrity, microvascular blood flow and capillary function. In this general discussion, we intend 
to touch on several aspects of cSVD that emerged after reviewing the results in this thesis.
1. The results of our studies have shed light on several aspects of the pathophysiology of cSVD 
but interpretation of some of the findings remains challenging. This especially concerns 
the IVIM studies. We will discuss the potentials and limitations of IVIM in studying cSVD.
2. Our studies addressed several pathophysiological aspects of cSVD. We propose a new 
concept in viewing cSVD and cSVD related mechanisms, which encompasses all proposed 
pathophysiological mechanisms in one concept: dysfunction of the neurovascular unit.
3. We will elaborate on future perspectives for research in cSVD
POTENTIALS AND LIMITATIONS 
OF IVIM IN STUDYING CSVD 
IVIM is an MRI technique targeted at the microvascular and microstructural level. In contrast 
to other diffusion and perfusion techniques, IVIM discerns brain parenchyma and vascular 
microcirculation, providing more uncontaminated data of the microstructural integrity and 
microvascular blood flow. Furthermore, IVIM is a patient-friendly technique, as it does not 
require the use of exogenous contrast agents. Due to these characteristics, IVIM has great poten-
tial in studying cSVD. 
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The parameters of IVIM have been examined concurrently with more conventional techniques 
such as arterial spin labelling: IVIM parameters f (blood volume fraction) and fD* (blood flow) 
correlated with cerebral blood volume (CBV) and cerebral blood flow (CBF) respectively.2-4 
However, as IVIM is a relatively new technique in the study of cSVD and we applied IVIM 
in a relatively small sample, the interpretation of our results is not straightforward and often 
hypothetical.
Unexpectedly, we found a higher blood volume fraction in normal appearing brain tissue in 
cSVD patients compared with healthy controls (chapter 4). We proposed that the higher blood 
volume fraction may be explained by vasodilation and/or increased vessel tortuosity. Moreover, 
contribution of glymphatic drainage that takes places in the perivascular spaces may play an 
important role. If glymphatic movements are detected by IVIM as vascular movements, the 
blood volume fraction is likely to be higher in patients with cSVD as cSVD is associated with 
enlarged perivascular spaces and indirectly with more glymphatic transport.5 
In the on-going research of our group, we tried to determine whether IVIM can isolate perivas-
cular water diffusion from the parenchymal and microvascular water diffusion. Preliminary data 
suggest that – apart from vascular and parenchymal movements – a third type of water move-
ment can be distinguished in preselected regions of interest with enlarged perivascular spaces.6 
As there are no other techniques to measure water movements specifically in the perivascular 
spaces, the interpretation of this data remain undetermined and are at the moment hypothetical. 
Perivascular spaces surround arteries and veins in the brain and are considered part of the 
glymphatic system that is essential for the clearance of cerebral waste.7 Moreover, they seem 
to play an important role in inflammatory processes.7 Increasing evidence is available on the 
association between enlarged perivascular spaces and cSVD.5, 7 However, the clinical significance 
of perivascular spaces remains controversial. Most studies are based on visual rating scales of 
perivascular spaces but as perivascular spaces are small and largely invisible on structural MRI, 
the interpretation of study findings is not straightforward.7 IVIM provides information at the 
microvascular/microstructural level and as it measures water movements rather than structures, 
it may potentially provide more functional information on perivascular spaces.
In chapter 5, we hypothesized that both microstructural integrity and microvascular blood 
flow as measured by IVIM are related to cognitive function in patients with cSVD, and possibly 
interact with each other. Although we found that patients with cSVD have lower microstructural 
integrity than controls and that lower microstructural integrity is associated with higher white 
matter hyperintensities (WMH) load (chapter 4), we found no association between microstruc-
tural integrity and cognitive function (chapter 5). Moreover, the association between lower 
microvascular blood flow and lower cognitive function was not mediated by microstructural 
integrity. Our results are in contrast to earlier diffusion tensor imaging (DTI) studies that found 
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an association between cognitive function and microstructure. A factor that may have contrib-
uted to these contrasting results could be the single directionality of our protocol. Moreover, in 
contrast to DTI, the diffusivity parameter acquired by IVIM was not contaminated by vascular 
influence, which also may have contributed to the different results. However, apart from meth-
odological differences, other aspects are likely to be involved: cognitive function is influenced 
by such an extensive number of factors that to demonstrate an association with microstructure 
is difficult with a small sample size. These factors include age, education, anxiety, depression, 
medication and genetics. The complex nature of cognition is why MRI markers - such as WMH 
load - are often used as surrogate markers for SVD rather than clinical outcomes such as cog-
nition. Indeed, we showed an association between lower microstructural integrity and higher 
WMH load. Future IVIM studies with larger sample size may provide more insights in the 
association between cognition and microstructure. 
NEUROVASCULAR UNIT: 
THE HOLY GRAIL OF UNDERSTANDING CSVD? 
cSVD is associated with several pathophysiological mechanisms including BBB leakage, change 
of cerebral blood flow, capillary dysfunction, endothelial activation and inflammation.1 The 
neurovascular unit (NVU) is a functional-anatomical entity that is composed of microvascular 
endothelium, basal membrane, astrocytes, pericytes, microglia and neurons.8 The above-men-
tioned mechanisms associated with cSVD all seem to relate to dysfunction of parts of the NVU. 
Instead of focusing on individual pathophysiological processes related to the different individual 
components, perhaps NVU dysfunction as a whole should be the future target of cSVD research. 
Blood-brain barrier function and its relation with the neurovascular unit
In chapter 2, we applied DCE-MRI and quantified BBB leakage. We demonstrated that cSVD is 
associated with a larger fraction of brain tissue that shows BBB leakage. Increased BBB leakage 
indicates endothelial dysfunction or damage, which is in accordance with earlier studies that 
proposed that endotheliopathy is one of the hallmarks of cSVD.1, 9
The endothelium in cerebral microvessels differs from the endothelium in the remainder body 
by the presence of tight junction (TJ) proteins. TJ proteins form interendothelial bonds and 
restrict paracellular diffusion from the capillary to the neuropil. Large molecules (>1000Da) as 
well as polar solutes need transporters to pass this barrier. Moreover, the intact endothelium 
maintains an antithrombotic environment through expression of heparin sulphates and gener-
ation of prostacyclin, adenosine and nitric oxide. Due to these characteristics, the endothelium 
is viewed as the main anatomical substrate that forms the BBB.8, 10
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Apart from endothelial contribution, the basal membrane, astrocytes, pericytes and microglia 
also play important roles in BBB function. The basal membrane separates the endothelium 
and the surrounding glia cells. It is composed of extracellular matrix proteins produced by 
endothelial cells, pericytes and astrocytes. These matrix proteins are characterized by a negative 
electric charge, which serves as an extra barrier for negative charged molecules from the circu-
lation.11 In cSVD, the basal membrane is thickened and morphological changes occur, resulting 
in functional changes.12 Astrocytes are essential in BBB differentiation and permeability reg-
ulation. Ablation of astrocytes leads to loss of barrier integrity and increased permeability.10, 11 
Pericytes lie within the microvessel wall, between the endothelial cells and astrocytes. They are 
responsible for the development and maturation of the BBB. Later in life, pericytes are essential 
for the stability of the BBB and maintaining its integrity.10, 13 Studies have shown that pericytes 
degeneration is associated with cSVD.14 
Thus, disruption of any of the NVU components may initiate or contribute to BBB leakage, 
resulting in extravasation of toxic metabolites from the circulation into the surrounding tissue. 
This may induce perivascular and parenchymal microglia activation and subsequently inflam-
mation.10 It is thinkable that whether or not neuronal damage occurs, and to which extent, 
does not depend on a single feature such as endothelial dysfunction but on the interaction of 
all these NVU components. 
We did not find an association between BBB leakage and cognitive function or WMH volume 
in patients with cSVD (chapter 3). However, we found that higher leakage rate was associated 
lower cognitive function in healthy controls. This suggests that in general, BBB leakage may 
have a role in cognitive decline but that in cSVD the mechanisms of cognitive decline are more 
complex. Cognitive function in cSVD may be determined not only by the extent of BBB leakage 
but also by the reaction of the surrounding astrocytes, pericytes, microglia and neurons to such 
leakage. Thus, the NVU as a whole may be the key to cognitive function and decline in cSVD.
Capillary dysfunction and its relation with the neurovascular unit
Adequate neuronal functioning demands a well-functioning NVU.15 Neurovascular coupling is 
regulated by the NVU. When neurovascular coupling is intact, increased metabolic demands 
will result in increased local perfusion and increased oxygen extraction. Under normal condi-
tions, oxygen extraction increases with increase of capillary oxygen tension, oxygen exchange 
surface and capillary transit time.12 Capillary transit time is determined by capillary blood cell 
velocity.12, 16 When capillaries are well-perfused, a high capillary transit time (i.e. low blood cell 
velocity) is associated with a larger maximum oxygen extraction fraction as oxygen molecules 
have more time to diffuse from the circulation to the brain parenchyma. 
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Under normal resting condition, capillaries in a capillary network are not perfused equally, 
resulting in a heterogeneous pattern of blood cell velocities across the network.17 As the met-
abolic demands are low and oxygen extraction is sufficient for the level of neural activity, it is 
not necessary to perfuse all capillaries. When metabolic demand rises, neurons and astrocytes 
induce blood flow increase at the arterial and arteriolar level by releasing vasodilators including 
nitric oxide and prostaglandin that operate through smooth muscle cells in the vascular wall.12 
This increase of cerebral blood flow (CBF) leads to a higher oxygen tension in the perfused 
capillaries. Moreover, it ensures a better perfusion of capillaries that otherwise are not or mini-
mally perfused. We refer to this increase of perfused capillary density as capillary recruitment. 
Capillary recruitment not only enlarges the oxygen exchange surface but also ensures that the 
capillary transit time remains high, enabling an optimal oxygen extraction efficacy and adequate 
neurovascular function. 
Recently, it has been hypothesized that capillary dysfunction may play a role in cSVD.18 In 
an early stage, this is compensated by arterial and arteriolar dilatation (hyperaemia), which 
increases oxygen tension. This may explain why some studies found an increased CBF in cSVD. 
However, due to capillary dysfunction, there is no increase in oxygen exchange surface, resulting 
in a low capillary transit time. In later disease stages, the oxygen extraction fraction becomes 
so critical that arteries and arterioles constrict to lower the CBF in order to increase the capil-
lary transit time and preserve efficient oxygen extraction. It has been hypothesized that if this 
suppression of CBF reaches the critical point of 21/ml/100ml, ischemia can occur even in the 
absence of a stenosis or a thrombotic or embolic source.18 
Age and cardiovascular risk factors related cSVD is considered part of a systemic small vessel 
disease that can involve the small vessels of various organs.1 Earlier sublingual microvascular 
measurements have shown significant differences in patients with cSVD compared with con-
trols.19 In patients with cSVD, we found that the sublingual perfused capillary density does not 
respond to increase of afferent blood flow (chapter 6). Moreover, when feed vessel red blood 
cell (RBC) velocity increases, the capillary RBC velocity increases significantly more in patients 
with cSVD compared with healthy controls. Both findings suggest that the capillary recruitment 
capacity is diminished in patients with cSVD. Our results are in accordance with the proposed 
hypothesis of capillary dysfunction of cSVD.18 Disruption of recruitment capacity means reduc-
tion of oxygen exchange surface as well as reduced capillary transit time. 
The origin of capillary dysfunction is unknown. Risk factors including ageing, hypertension and 
diabetes have been shown to cause changes to the endothelium, astrocytes, pericytes and micro-
glia. Changes to these NVU components are assumed to contribute to capillary dysfunction.20 
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Particular emphasis has been put on the role of pericytes in neurovascular coupling. Pericytes 
that surround the capillaries appear to have an even faster vasodilatory reaction to neural activ-
ity than smooth muscle cells.14, 15 They regulate the capillary diameter and may therefore play 
a pivotal role in recruitment of functional capillaries by dilation of capillaries that otherwise 
are constricted and not functional. Ischemia was shown to induce irreversible constriction of 
pericytes and compromise capillary flow.14
Dysfunction of the neurovascular unit
We propose a new view on the pathophysiological concept for cSVD: dysfunction of the NVU. 
This concept encloses and connects various individual pathophysiological mechanisms and 
proposes that cSVD concerns dysfunction of multiple components of the NVU. As the NVU is a 
well-arranged, interconnected regulation system, different initial disruptions involving different 
NVU components may elicit a series of processes that eventually lead to similar end-stage lesions 
that we associate with cSVD. cSVD is not a disease of the small vessels, but a disease of the NVU. 
FUTURE PERSPECTIVES 
Based on earlier studies and current data, we hypothesize that the pathophysiological mecha-
nisms of cSVD are interrelated and are linked to the different functions of the NVU. 
However, to examine the NVU in vivo in human remains difficult. Human, in vivo studies 
fail to reach a high spatial resolution.15 The average distance from microvessel to neuron is 30 
micrometres. Thus, a 2mm lesion – which can be detected on conventional MRI – would contain 
1x105 NVUs and hundreds of capillaries. Therefore, abnormalities on conventional MRI must 
involve a great number of NVUs. Conversely, brain tissue can already be damaged despite its 
normal appearance on MRI. Microscopic structural changes may start years before the first 
radiological abnormalities and clinical symptoms of cSVD appear.21
Although it is not yet possible to examine the NVU in its entirety in vivo in human, it is desirable 
to perform studies that focus on multiple aspects of the NVU simultaneously as the functions 
of the NVU cannot be seen as independent mechanisms. Future studies should use different 
imaging modalities simultaneously and the results from these different modalities should be 
studied as a whole. For example, it would be interesting to combine the results of capillary 
recruitment and the microvascular blood flow results acquired by IVIM. However, these studies 
require larger sample sizes. This may be realised by performing multicentre studies. An example 
of such endeavour is the SVDs@target project in which our research group is participating. 
The project aims to apply different technologies in animal models as well as patient cohorts 
to identify the pathophysiological mechanisms of cSVD. In time, studies may provide more 
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insight in how different NVU components interact with each other and with exogenous trig-
gers, eventually leading to interventions that can stop or perhaps even prevent the vicious cycle 
leading to NVU dysfunction and the clinical disabilities associated with cSVD. Finally, in vitro 
as well as ex vivo studies may also be of great value in achieving a better understanding of the 
function and dysfunction of the NVU in cSVD. Co-cultures with endothelial cells, astrocytes, 
pericytes and microglia could provide a more in depth comprehension of the processes of the 
NVU and what may go wrong when manipulated. Creating such an NVU model incorporating 
all cell types as well as the influence of blood flow will be challenging. Yet, such model may 
enable close examination of cSVD and for instance how ageing and cardiovascular risk factors 
contribute to the development of cSVD.22-25 Earlier ex vivo studies using rat brain cells have 
provided essential information on the role of pericytes in the NVU.13, 26 Moreover, a BBB model 
acquired from Spontaneous Hypertensive Stroke Prone (SHRSP) rats – the most widely used rat 
model for cSVD – has shown that astrocytes are important in the regulation of brain endothe-
lial fibrinolysis, an integral part of inflammation and the prevention of thrombus formation.27 
Moreover, using the genetically hypertension mice model BPH/2J, perivascular macrophages 
have been shown to be critical in the neurovascular regulation as it mediates BBB permeability 
and contributes to the release of reactive oxygen species (ROS).28 Ex vivo models of cSVD such 
as the SHRSP and BPH/2J models should be further explored and the influence of all the compo-
nents of the NVU should be examined simultaneously. For instance, by isolating cerebral small 
vessels and their surrounding tissue (i.e. including the NVU components) from these rats and 
expose them to various stimuli such as arteriolar pressure increases, hyperglycaemic states but 
also induction of nitric oxide, a better understanding of the pathophysiology may be achieved. 
In conclusion, we propose that cSVD is not solely a disease of the small vessels but a disease of 
the NVU comprising all its elements. This shift in pathophysiological paradigm will provide new 
perspectives in cSVD research and may eventually lead to the development of new preventative 
and therapeutic interventions.
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SUMMARY
Cerebral small vessel disease (cSVD) is an age and cardiovascular risk factors related disor-
der and encompasses a spectrum of pathologies affecting the small vessels of the brain. It is 
associated with structural abnormalities on brain MRI including white matter hyperintensities 
(WMH), cerebral microbleeds, lacunes and perivascular spaces. Moreover, cSVD is considered 
the underlying cause for lacunar stroke and vascular cognitive impairment (VCI). Despite the 
increasing prevalence of cSVD in our ageing society and the impact of cSVD on public health, 
the pathophysiology of cSVD remains unclear. Various processes have been considered to be 
involved in cSVD including blood-brain barrier (BBB) dysfunction, loss of microstructural 
integrity, changes in cerebral blood flow, inflammation and capillary dysfunction. However, the 
exact pathophysiological pathways remain elusive. 
As cSVD is a chronic disease and not associated with acute mortality, in vivo imaging studies 
are essential in unraveling the pathophysiological processes associated with cSVD. Many con-
ventional CT and MRI studies have been performed with this aim but with the availability of 
more sophisticated imaging techniques other aspects of cSVD can now be examined. 
The general aim of this thesis was to gain further insights in the pathophysiological processes 
of cSVD, using new quantitative imaging techniques including dynamic contrast-enhanced 
(DCE) MRI, introvoxel incoherent motion (IVIM) MRI and sublingual intravital microscopy. 
By comparing patients with cSVD and healthy controls, we aimed to acquire more knowledge 
on the role of BBB dysfunction, microstructural and microvascular flow changes, and capillary 
dysfunction, in cSVD. Moreover, we aimed to determine the relationships between these pro-
cesses and structural radiological markers and clinical outcome parameters. 
In chapter 2, we used DCE-MRI to examine whether BBB leakage is increased in 77 patients 
with cSVD compared with 39 healthy controls. We quantified the leakage rate and leakage 
volume in the normal appearing white matter (NAWM), WMH and cortical grey matter (CGM). 
We found that patients with cSVD showed larger leakage volume of the NAWM, WMH and 
CGM compared with controls. This finding supports the concept of BBB dysfunction in cSVD 
and the diffuse nature of microvascular endothelial failure in cSVD, as this difference was found 
in the NAWM, in the WMH as well as in the CGM. We found no significant difference for 
leakage rate between patients and controls.
To determine whether BBB leakage relates to radiological cSVD markers and clinical parame-
ters, we investigated whether BBB leakage volume and leakage rate were associated with WMH 
volume and cognitive function, both in cSVD patients and in healthy controls. This is presented 
in chapter 3. Larger leakage volume and lower leakage rate in the WMH were associated with 
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larger WMH volume in cSVD patients. Moreover, higher leakage rate in the NAWM was associ-
ated with lower scores on the cognitive domains executive function and information processing 
speed, in healthy controls, but not in patients. We concluded that BBB leakage appeared to be 
involved in cognitive function in healthy ageing but that in cSVD it is likely that cognition is 
confounded by other mechanisms such as lacunar infarcts and cerebral perfusion. 
In chapter 4, we used IVIM MRI to investigate the microstructural integrity, microvascular 
blood flow and microvascular blood volume fraction simultaneously. This was performed in 
73 patients with cSVD and in 39 healthy controls. Earlier studies examined microstructural 
integrity and blood flow changes in cSVD but rarely were the two parameters examined con-
currently. Our results showed that patients with cSVD had a lower microstructural integrity 
and higher blood volume fraction in the NAWM and CGM, and similar microvascular blood 
flow, compared with controls. Lower microstructural integrity in cSVD is in accordance with 
earlier findings and is indicative of neurodegenerative processes. Higher blood volume fraction 
may be due to vasodilation and/or increased vessel tortuosity but more studies are needed to 
understand this finding. 
We examined the relationship between microstructural integrity, microvascular blood flow and 
cognitive function in patients and in controls, in chapter 5. Lower microvascular blood flow 
in the NAWM and CGM was related to lower cognitive performance. This finding supports 
the role of microvascular blood flow changes in the pathophysiology of cSVD. We found no 
interaction between microvascular integrity and microvascular blood flow in their association 
with cognitive function. This lack of direct interaction may reflect the multifactorial nature of 
the pathophysiology of cognitive dysfunction in cSVD. 
In chapter 6, we looked at the relationship between sublingual microvascular blood flow and 
capillary density in 15 male patients with VCI due to cSVD and 15 controls. Healthy controls 
showed a proportionate increase of capillary density with increase of feed vessel blood flow, 
whereas in patients with VCI, no increase of capillary density was observed. This flow-density 
uncoupling led to an increase of capillary red blood cell velocity in patients with VCI, which in 
turn may impair oxygen and nutrients exchange capacity and eventually tissue damage.
In Chapter 7, we discussed three issues that emerged from the study findings. Firstly, we elab-
orated on the potentials and limitations of IVIM in studying cSVD. IVIM is developed with 
the potential to discern parenchymal integrity and vascular blood flow and therefore may shed 
new light on the pathophysiology of cSVD. Moreover, IVIM is a patient-friendly technique, as 
it does not require exogenous contrast agents. However, IVIM is also a relatively new technique 
in studying cSVD and more studies are needed to confirm the validity of the results and the 
interpretation of the findings, as these findings are not always consistent with earlier findings. 
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Secondly, we propose a new pathophysiological concept for cSVD. Up till now, cSVD has been 
regarded as a disorder of the small vessels, which occurs due to a range of processes including 
BBB leakage, inflammation, endothelial activation and changes of blood flow. However, as we 
have observed that the pathophysiology of cSVD is complex and multifactorial, and the mul-
tiple aspects of the pathophysiology can all be traced back to the different components of the 
neurovascular unit (NVU), it may be more just to depict cSVD as a disorder of the NVU rather 
than a microvascular disorder. Finally, we discussed that in the future, it is desirable to perform 
studies that focus on multiple aspects of the NVU simultaneously. Different imaging modalities 
should be combined and used concurrently to study the functions of the NVU as an entity. In 
vitro and ex vivo studies may also contribute to the elucidation of the function and dysfunction 
of the NVU in cSVD. By shifting the emphasis from micro vessels to the NVU, future studies 
may provide a more coherent understanding of the pathophysiology of cSVD and eventually 
lead to the development of preventative and/or therapeutic interventions for cSVD.
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Cerebral small vessel disease (ziekte van de kleine bloedvaten in de hersenen; cSVD) is een ziekte 
die sterk gerelateerd is aan leeftijd en cardiovasculaire risicofactoren. Het omvat een spectrum 
van aandoeningen van de kleine bloedvaten van de hersenen. cSVD is geassocieerd met 
structurele afwijkingen die gezien kunnen worden op hersen-MRI’s: wittestofhyperintensiteiten 
(WMH), cerebrale microbloedingen, lacunes en perivasculaire ruimtes. cSVD wordt beschouwd 
als de onderliggende oorzaak van lacunaire herseninfarcten en vasculaire cognitieve stoornissen 
(VCI). Ondanks dat de prevalentie van cSVD in onze maatschappij toeneemt en cSVD een 
enorme impact heeft op de volksgezondheid, blijft de pathofysiologie ervan nog grotendeels 
onopgehelderd. Verschillende mechanismen lijken betrokken te zijn bij cSVD: disfunctie van 
de bloed-hersenbarrière (BBB), verminderde microstructurele integriteit, veranderingen van 
de cerebrale blood flow, inflammatie en capillaire disfunctie. De exacte pathofysiologie blijft 
echter onduidelijk.
cSVD is een chronische ziekte en is niet geassocieerd met acute mortaliteit. Hierdoor zijn in vivo 
beeldvormende onderzoeken essentieel voor het ontrafelen van de pathofysiologie van cSVD. 
Er zijn al veel conventionele CT- en MRI-studies uitgevoerd met het doel de pathofysiologische 
mechanismen te achterhalen, maar met de komst van nieuwe beeldvormingstechnieken kunnen 
steeds meer aspecten van cSVD worden onderzocht.
Het doel van deze thesis was het verwerven van meer inzichten in de pathofysiologie van cSVD 
door gebruik te maken van nieuwe, kwantitatieve beeldvormingstechnieken zoals de dynamic 
contrast-enhanced (DCE) MRI, de intravoxel incoherent motion (IVIM) MRI en de sublingual 
intravital microscopie. Door patiënten met cSVD en gezonde controle personen met elkaar te 
vergelijken, hebben we geprobeerd meer kennis te verkrijgen over de rol van BBB-disfunctie, 
capillaire disfunctie, en microstructurele en microvasculaire flow-veranderingen, bij patiënten 
met cSVD. Daarnaast was het doel om te onderzoeken hoe de relaties zijn tussen deze processen 
en de MRI-markers, en tussen deze processen en klinische parameters zoals cognitie. 
In hoofdstuk 2 hebben we met DCE-MRI onderzocht of de BBB-lekkage was toegenomen in 77 
patiënten met cSVD, in vergelijking met 39 gezonde controles. We hebben de lekkagesnelheid 
en het lekkagevolume gekwantificeerd in de normaal uitziende witte stof (NAWM), in WMH 
en in de corticale grijze stof (CGM). Patiënten met cSVD laten een groter volume met lekkage 
zien in de NAWM, WMH en CGM in vergelijking met gezonde controles. Deze bevinding 
ondersteunt het pathofysiologisch concept van BBB disfunctie bij cSVD en daarnaast de diffuse 
aard, aangezien zowel NAWM als WMH en CGM betrokken lijken te zijn. We hebben geen 
significant verschil gevonden in de lekkagesnelheid tussen patiënten en controles.
APPENDIX
130
Om vast te stellen of BBB-lekkage gerelateerd is aan radiologische cSVD-markers en klinische 
parameters, hebben we onderzocht of het volume en de snelheid van BBB-lekkage geassocieerd 
is met het WMH-volume en de cognitieve functie. Dit is gedaan bij patiënten met cSVD en 
controles en de resultaten werden gepresenteerd in hoofdstuk 3. Een groter lekkagevolume en 
een lagere lekkagesnelheid in de WMH bleken geassocieerd te zijn met grotere WMH-volumes 
in patiënten met cSVD. Daarnaast is een hogere lekkagesnelheid in de NAWM geassocieerd met 
lagere scores op de cognitieve domeinen executieve functie en informatie verwerkingssnelheid. 
Dit werd bij gezonde controles gevonden maar niet bij patiënten. Wij concludeerden dat BBB-
lekkage betrokken lijkt te zijn bij het cognitief functioneren bij gezonde veroudering, maar dat 
de cognitie bij cSVD mogelijk bepaald wordt door meerdere mechanismen, waardoor dit niet 
duidelijk terug te voeren is naar alleen BBB-lekkage. 
In hoofdstuk 4 hebben we bij 73 cSVD-patiënten en 39 controles middels IVIM MRI gelijktijdig 
gekeken naar de microstructurele integriteit, de microvasculaire blood flow en de microvasculaire 
bloedvolumefractie. Eerdere studies hebben ook naar microstructurele integriteit en blood flow-
veranderingen onderzocht maar zelden werden de twee parameters tegelijkertijd bestudeerd. 
Onze resultaten lieten zien dat patiënten met cSVD in vergelijking met controles een lagere 
microstructurele integriteit en een hogere bloedvolumefractie hadden in de NAWM en CGM. 
Daarnaast was er geen significant verschil in microvasculaire blood flow tussen patiënten en 
controles. De lagere microstructurele integriteit bij cSVD patiënten komt overeen met eerdere 
bevindingen en duidt op neurodegeneratieve processen. De grotere bloedvolumefractie wordt 
mogelijk verklaard door vasodilatatie en/of toename van vaattortuositeit. Voor een goed begrip 
van het mechanisme vereist deze bevinding echter meer onderzoek. 
In hoofdstuk 5 hebben we de relatie onderzocht tussen microstructurele integriteit, 
microvasculaire blood flow en cognitieve functie, zowel bij patiënten met cSVD als bij controles. 
Lage microvasculaire blood flow in de NAWM en CGM was gerelateerd aan een lage cognitie. 
Deze bevinding ondersteunt de rol van microvasculaire blood flow-veranderingen in de 
pathofysiologie van cSVD. We hebben geen interactie gevonden tussen de microvasculaire 
integriteit en de microvascluaire blood flow met betrekking tot hun associatie met cognitie. 
Dit gebrek aan directe interactie duidt mogelijk op een multifactoriële oorzaak van cognitieve 
disfunctie bij patiënten met cSVD. 
De relatie tussen sublinguale microvasculaire blood flow en capillaire dichtheid werd onderzocht 
in hoofdstuk 6. Dit werd gedaan bij 15 mannelijke patiënten met VCI ten gevolge van cSVD en 
bij 15 gezonde mannelijke controles. De gezonde controles lieten een proportionele toename zien 
van de capillaire dichtheid met een toename van de blood flow in de aanvoerende bloedvaten. In 
patiënten met VCI werd geen toename van capillaire dichtheid gezien bij deze verandering. Een 
dergelijke flow-dichtheidontkoppeling leidt tot een snelheidstoename van de rode bloedcellen in 
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de capillairen bij patiënten met VCI. Dit kan resulteren in een gestoorde uitwisselingscapaciteit 
van zuurstof en voedingsstoffen en kan uiteindelijk leiden tot weefselschade. 
In hoofdstuk 7 bediscussieerden we een drietal zaken die naar voren zijn gekomen naar 
aanleiding van de onderzoeksbevindingen. Ten eerste gaan we in op de potenties en beperkingen 
van het gebruik van IVIM-MRI in het onderzoeken van cSVD. IVIM is ontwikkeld met de 
mogelijkheid om de parenchymale integriteit en de microvasculaire blood flow los van elkaar 
maar wel tegelijkertijd te onderzoeken. Dit scheidingsvermogen kan nieuwe inzichten bieden in 
de pathofysiologie van cSVD. IVIM-MRI is daarnaast een patiëntvriendelijke techniek omdat 
het geen toediening van een exogene contrastvloeistof vereist. IVIM is echter ook een relatief 
nieuwe methode in het onderzoeken van cSVD en meer studies zijn nodig om de validiteit en 
interpretatie van de resultaten te bevestigen. Ten tweede stellen we een nieuwe hypothese voor 
met betrekking tot de pathofysiologie van cSVD. Tot nu toe wordt cSVD primair gezien als 
een aandoening van de kleine bloedvaten. We zien dat de pathofysiologie van cSVD complex 
en multifactorieel is, maar ook dat alle aspecten terug te brengen zijn naar de verschillende 
onderdelen van de neurovasculaire unit (NVU). Het is naar onze mening daarom doelmatiger 
om cSVD te zien als een aandoening van de NVU in plaats van een aandoening van de kleine 
bloedvaten. Tot slot stellen we dat het wenselijk is dat toekomstige studies de verschillende 
aspecten van de NVU meenemen: verschillende beeldvormende technieken zouden moeten 
worden gecombineerd en tegelijkertijd worden ingezet om de verschillende functies van de 
NVU als één geheel te onderzoeken. Ook in vitro- en ex vivo-studies kunnen bijdragen aan het 
verhelderen van de functies en disfuncties van de NVU bij cSVD. Door de nadruk te verschuiven 
van microvaten naar de NVU kunnen we met toekomstige studies een beter begrip krijgen van 
het totaalbeeld van de pathofysiologische mechanismen die betrokken zijn bij cSVD. Dit kan 
uiteindelijk leiden tot de ontwikkeling van preventieve en/of therapeutische behandelingen bij 
cSVD. 
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Life expectancy is increasing in our current society, as well as health, social and economic bur-
dens that come along with it. Stroke and dementia are two major examples of ageing-related 
disorders. Annually, 15 million people worldwide suffer a stroke. Of these, 5 million die and 
another 5 million are left permanently disabled, placing a burden on family and community.1 In 
Europe, the annual economic cost of stroke is an estimated €27 billion: €18.5 billion for direct 
costs and €8.5 billion for indirect costs. An additional €11.1 billion is calculated for the value 
of informal care.2 Worldwide, around 50 million people have dementia, and there are nearly 10 
million new cases every year. The total number of people with dementia is projected to reach 
82 million in 2030 and 152 million in 2050. Dementia is one of the major causes of disability 
and dependency among older people worldwide. Dementia has a physical, psychological, social, 
and economical impact, not only on people with dementia, but also on their carers, families and 
society at large. In 2015, the total global societal cost of dementia was estimated to be US$ 818 
billion, and with our ageing society, these costs are expected to rise continually on a global level.3
Cerebral small vessel disease (cSVD) is a disorder involving the small vessels in the brain. It is 
considered the underlying cause of lacunar stroke, which forms twenty per cent of all strokes. 
Moreover, cSVD is a major contributor to cognitive impairment and dementia.4 So far, no effec-
tive treatments exist for cSVD. Treatment of lacunar stroke is focused on cardiovascular risk 
reduction.1 However, this mainly targets the later stages of the disease when the initial damage 
is already done. In the care for patients with dementia, providing information and long-term 
support is the only care that is available. Currently, there are no therapies to cure dementia or 
to alter its progressive course.3 In order to develop effective treatments for stroke and dementia, 
a better understanding of the pathophysiology of cSVD is indispensable.
One of the challenges in cSVD research is that cSVD is a chronic disease and it takes years if not 
decennia for the disease to evolve from its initial stages to the stage with clinical symptoms. To 
understand the disease in depth, studies in all stages are essential. As cSVD is not associated with 
acute mortality, in vivo studies in especially the early stages are not easily performed. So far, in 
vivo studies using conventional imaging techniques have provided a fairly amount of informa-
tion on the processes occurring in cSVD. However, to acquire a more in depth understanding 
of the pathophysiology, more advanced methods are needed. Quantitative dynamic contrast-en-
hanced (DCE) MRI, intravoxel incoherent motion (IVIM) MRI and intravital microscopy are 
advanced imaging techniques that may enhance our knowledge of cSVD.
Using DCE-MRI, we quantified the blood-brain barrier leakage in patients with cSVD and 
healthy controls. Our observations confirmed that blood-brain barrier leakage was associated 
with cSVD and that this leakage occurred in the white matter as well as cortical grey matter. 
These results underlined diffuse endothelial dysfunction in cSVD. Using IVIM MRI, we found 
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that higher microvascular blood flow was associated with cognitive function in patients with 
cSVD compared with controls, suggesting a direct link between blood flow and cognition. 
Furthermore, capillary dysfunction appeared to relate to patients with cSVD. These findings 
provide more insights in the pathophysiology of cSVD.
In addition, by proposing a dysfunctional neurovascular unit as the underlying cause of cSVD, 
we provide future directives in the research of cSVD. As so many processes appear to play a 
role in the pathophysiology of cSVD, it is desirable to look at these processes as an entity. This 
approach may elucidate the interactions between the processes and as such provides a better 
understanding of cSVD. 
In various ways, our study contributes to a better understanding of cSVD, supports the devel-
opment of new imaging techniques and their analysis and interpretation, and sets a path for 
further research. Although this is not a direct valorisation for society at this very moment and 
the imaging techniques have no clinical value yet, this knowledge may eventually lead to the 
development of effective diagnostic means and treatments of cSVD, enabling early detection 
and stabilization or even cure of cSVD, which in turn may alleviate the socio-economic burden 
that stroke and dementia impose on our society.
_______________
1. WHO. Global burden of stroke. http://www.who.int/cardiovascular_diseases/resources/atlas/en/. 
2. Di Carlo A. Human and economic burden of stroke. Age Ageing. 2009;38:4-5
3. WHO. Dementia. http://www.who.int/news-room/fact-sheets/detail/dementia. 
4. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic chal-
lenges. Lancet Neurol. 2010;9:689-701
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buitenlandse woordenboek van mijn reis. Ik heb weliswaar geen technische achtergrond maar 
de discussies met jou en May over het gebruik van wiskundige modellen en de betekenis van 
de MRI-bevindingen waren boeiend en leerzaam. Je hield de stof uitdagend door er de potentie 
van toepassingen aan te koppelen. Dank hiervoor. Daarnaast ook dank voor je kritische blik 
op de manuscripten, voor het sturen van de richting van het onderzoek en voor je gezelschap 
tijdens de treinreizen van en naar Roermond.
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Lieve Adinda, Seline, Zoë, Rebecca, Rob, Roos, Marjan, Lynn, Marlous, Samantha, Janneke 
en Monica. Dank jullie wel voor jullie vriendschappen door de jaren heen, dat we al die tijd 
contact zijn blijven houden, en de ups en downs van het leven hebben gedeeld. Ik ben zo intens 
blij met jullie!
Lieve Martien, Gerrie, Petra, Bram, Karlien en Gerardo, dank voor jullie betrokkenheid en 
gezelligheid de afgelopen jaren, en hulp bij het bouwen van een thuis voor Leo en mij. Ik ben 
trots en dankbaar dat ik jullie familie mag noemen.
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reis, maar jij bent het begin van een nieuw avontuur. Dank je dat je in ons leven bent gekomen 
en ons ontroert met je blik, je lach en je gebrabbel. Ik hou van jou. 
Lieve Leo, woorden schieten tekort als ik moet verwoorden wat je voor mij betekent. Jij laat me 
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OMSLAG
Op de voorkant van het omslag ziet u een magnolia: een boom met witte bloemen. De takken 
van de boom representeren de kleine bloedvaten in de hersenen die zich steeds fijner vertakken 
tot in de haarvaten. Aan het uiteinde van deze haarvaten ziet u de witte bloemen, die voor de 
zogenaamde wittestofafwijkingen staan die op een MRI van de hersenen te zien zijn bij patiënten 
met cerebral small vessel disease.
Daarnaast ziet u een meanderend landweggetje op het omslag, dat doorloopt naar de achterzijde 
van het boekje: het pad dat mijn onderzoeksteam en ik hebben bewandeld. Terwijl onze focus 
in het begin nog hoofdzakelijk bij de kleine bloedvaten en de wittestofafwijkingen lag (de 
voorzijde), heeft er in de loop van de studie een verschuiving plaatsgevonden. We eindigen 
met de conclusie dat we naar het breder plaatje moeten kijken: niet alleen kleine bloedvaten, 
maar ook naar de verschillende soorten hersencellen en hun onderlinge interacties, die een 
belangrijke rol spelen in deze ziekte (de achterzijde). De verschillende soorten hersencellen zijn 
weergegeven als kleurrijke bloemen in deze ‘onderzoekstuin’.
Tot slot, als u de voorzijde van dit boekje tegen de achterzijde van een tweede exemplaar legt, 
ziet u de boom in zijn geheel. Dit geeft het de nauwe samenwerking tussen de afdelingen 
Neurologie, Radiologie en Fysiologie weer, die de basis van dit onderzoek en uiteindelijk van 
de totstandkoming van dit boekje vormde. 
